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Abstract
Following a request from the European Commission, the EFSA Panel on Plant Protection Products and
their Residues (PPR Panel) prepared a scientiﬁc opinion to provide a comprehensive evaluation of
pesticide residues in foods for infants and young children. In its approach to develop this scientiﬁc
opinion, the EFSA PPR Panel took into account, among the others, (i) the relevant opinions of the
Scientiﬁc Committee for Food setting a default maximum residue level (MRL) of 0.01 mg/kg for
pesticide residues in foods for infants and young children; (ii) the recommendations provided by EFSA
Scientiﬁc Committee in a guidance on risk assessment of substances present in food intended for
infants below 16 weeks of age; (iii) the knowledge on organ/system development in infants and young
children. For infants below 16 weeks of age, the EFSA PPR Panel concluded that pesticide residues at
the default MRL of 0.01 mg/kg for food for infants and young children are not likely to result in an
unacceptable exposure for active substances for which a health-based guidance value (HBGV) of
0.0026 mg/kg body weight (bw) per day or higher applies. Lower MRLs are recommended for active
substances with HBGVs below this value. For infants above 16 weeks of age and young children, the
established approach for setting HBGVs is considered appropriate. For infants below 16 weeks of age
the approach may not be appropriate and the application of the EFSA guidance on risk assessment of
substances present in food intended for infants below 16 weeks of age is recommended. The
contribution of conventional food to the total exposure to pesticide residues is much higher than that
from foods intended for infants and young children. Because of the increased intake of conventional
food by young children, these have the highest exposure to pesticide residues, whereas infants 3–6
months of age generally have lower exposure. The impact of cumulative exposure to pesticide residues
on infants and young children is not different from the general population and the EFSA cumulative
risk assessment methodology is also applicable to these age groups. Residue deﬁnitions established
under Regulation (EC) No 396/2005 are in general considered appropriate also for foods for infants
and young children. However, based on a tier 1 analysis of the hydrolysis potential of pesticides
simulating processing, the particular appropriateness of existing residue deﬁnitions for monitoring to
cover processed food, both intended for infants and young children as well as conventional food, is
questionable.
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Summary
The European Commission asked the European Food Safety Authority (EFSA) to provide a
comprehensive evaluation of pesticide residues in foods for infants and young children by reviewing
the relevant opinions of the Scientiﬁc Committee for Food (SCF) of 1997/1998 in the light of scientiﬁc
progress and provide advice to the Commission on the approach to lay down protective rules on the
matter, taking into account the relevant provisions of Regulation (EU) No 609/2013. In the Opinion,
developed by the EFSA Panel on Plant Protection Products and their Residues (PPR Panel), the
following speciﬁc points of the Terms of Reference agreed with the Commission are covered:
1) The assessment of the appropriateness of the toxicological reference values for pesticides
for infants and young children and of the approach to base the maximum residue limits
(MRLs) for pesticides for food for infants and young children on the acceptable daily intake
(ADI) values (in this context, the assessment of the short-term dietary risk should also be
considered);
2) The assessment of the contribution of other foods consumed by infants and young children
that are not covered by Regulation (EU) No 609/2013;
3) The impact of a cumulative exposure to pesticides which share a common toxicological
effect;
4) The appropriateness of residue deﬁnitions established under Regulation (EU) No 396/2005
for foods for infants and young children.
In addition, the Commission requested to take into consideration in the assessment the experience
gained in the assessment of toxicological studies in the framework of the peer review under Regulation
(EC) No 1107/2009 (including speciﬁc guidelines developed in that context).
The EFSA PPR Panel noted that EFSA, in the context of its duties under Regulation (EC) 1107/2009,
has no speciﬁc experience with respect to the adequacy for infants and children of the hazard
identiﬁcation and characterisation process for pesticides active substances. Furthermore, a consultation
of the Member States through the Pesticide Steering Network revealed that, at a national level, no
such speciﬁc experience had been gained nor speciﬁc guidelines had been developed.
A literature search was performed to identify publications in the areas of toxicokinetics (TK), the
physiology of the gut, the nervous system, the immune system, the male and female reproductive
systems, the endocrine system in the developing infant and young child. The current evidence
indicates that the differences in these areas between infants above the age of 16 weeks and young
children and adults are rather limited in comparison with adults. In addition, it was noted that on a
body weight basis, therapeutic doses of pharmaceuticals used in infants and young children do not
differ much from those used in adults. Based on these ﬁndings, it was concluded that the ADI and the
acute reference dose (ARfD) can be applied to infants above 16 weeks of age and young children, and
that an additional assessment factor is not necessary for these age groups. For infants below the age
of 16 weeks, it was concluded that the current approach for setting ADI and ARfD may not be
appropriate and the application of the EFSA guidance on risk assessment of substances in food for
infants below 16 weeks of age (EFSA Scientiﬁc Committee, 2017) is recommended.
For infants below 16 weeks of age, the potential residue intake was calculated to be 0.0026 mg/kg
body weight (bw) per day. This calculation is based on an intake of infant formula of approximately
260 g/kg bw per day (EFSA Scientiﬁc Committee, 2017) and a default maximum pesticide residue level
of 0.01 mg/kg for the infant milk. The EFSA PPR Panel concludes that potential residues at the default
MRL of 0.01 mg/kg for food for infants and young children do not result in an unacceptable exposure
to infants for any compound for which a health-based guidance value (HBGV) of 0.0026 mg/kg bw per
day or higher applies. For pesticides with HBGVs lower than 0.0026 mg/kg bw after application of the
guidance on risk assessment of substances in food for infants (EFSA Scientiﬁc Committee, 2017), the
default MRL of 0.01 mg/kg for foods intended for infants and young children may not be sufﬁciently
protective, and for these pesticides, the approach to base MRLs on the HBGVs is considered
appropriate.
For infants older than 16 weeks of age and young children, new methodologies are proposed to
estimate combined exposure to pesticide residues via foods intended for infants and young children,
and via other foods not covered by Regulation (EU) No 609/2013 (also referred to as conventional
foods). Based on the observed dietary patterns, further distinction was made between infants 3–6
months of age, infants 6–12 months of age and young children (1–3 years of age, also often referred
as ‘toddlers’). In order to test the proposed methodologies, calculations were carried out for ﬁve case
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studies. These calculations showed that, generally, exposure was the highest for young children and
the lowest for infants from 3 to 6 months old. This increase in exposure with age is correlated to the
increasing consumption of conventional foods, which was the main source of exposure in all case
studies. The contribution of speciﬁc food intended for infants and young children to the overall
exposure was low. The commodities driving the exposures depended on the use pattern of the
pesticide under assessment. There were also large differences observed between exposures calculated
according to a premarketing scenario (i.e. based on residue ﬁeld trials when a pesticide active
substance is evaluated in view of its placing on the market) and exposures calculated according to a
post-marketing scenario (i.e. based on results from monitoring programmes after the pesticide, active
substance was placed on the market). Exposure estimates for the premarketing scenarios were 2–100
times higher compared to the post-marketing scenario.
With respect to the impact of cumulative exposure to pesticide residues on infants and young
children the current state of science and developments in the ﬁeld of cumulative risk assessment were
considered. It was concluded that the impact on infants and young children is not different from the
general population and that the cumulative risk assessment methodology of EFSA PPR Panel is also
applicable to these age groups.
In the European Union (EU), while residue deﬁnitions for monitoring are used to survey adequate
pesticide applications, they are also intended to allow an indicative, post-authorisation dietary risk
assessment. In this respect, the scope of the maximum residue levels in food for infants and young
children is not different to that for the general population. Residue deﬁnitions established under
Regulation (EC) No 396/2005 are therefore in general considered appropriate also for foods for infants
and young children. For monitoring and indicative risk assessment, the particular appropriateness of
existing residue deﬁnitions established under Regulation (EU) No 396/2005 for infant food as regulated
under Commission Directives 2006/125/EC and 2006/141/EC depends on whether potential changes in
the nature of residue by food-processing operations are covered by the actual expression of the
residue deﬁnition and by appropriate conversion factors if applicable. In the current opinion, an
analysis of the hydrolysis potential-simulating pasteurisation, baking/boiling and sterilisation conditions,
was performed on 111 pesticides with a single-compound residue deﬁnition. Under conditions
simulating pasteurisation, 4% of active substances considered showed recoveries of parent compound
less than 50%. Harsher conditions representative for baking/boiling and for sterilisation showed
instability in 12% and 21% of cases, respectively. Based on this analysis, it is concluded that there is
doubt on the general appropriateness of existing residue deﬁnitions for monitoring to cover processed
food, both intended for infants and young children as well as conventional food. Therefore, the EFSA
PPR Panel recommends to perform a detailed analysis considering all-embracing information for
pesticide active substances, including the ﬁeld residue situation of relevant compounds in the starting
material as well as realistic industrial-processing conditions.
EFSA PPR Panel makes the following additional recommendations. In order to address the relevant
period of exposure in animal studies, the EFSA PPR Panel notes that the Extended One-Generation
Reproductive Toxicity Study (EOGRTS, OECD TG443) with the developmental neurotoxicity (DNT) and
developmental immuno toxicity (DIT) cohorts and the DNT study (OECD TG426) are the only studies
that speciﬁcally address the postnatal period and this also includes periods similar to the age of 3
years in humans. It is, therefore, recommended that all pesticides should be screened for DNT
properties in a DNT in vitro testing battery (to be developed) and triggers for further regulatory
studies should be reconsidered. The DNT test guideline (OECD TG426) should be reviewed and
improved. Furthermore, if a reproductive study is to be performed, it should be the EOGRTS, including
a DIT and DNT cohorts.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
Relevant legal framework
Commission Directive 2006/125/EC1 and Commission Directive 2006/141/EC2 set speciﬁc
requirements on the use of pesticides in products intended for the production of and on pesticide
residues in infant formulae, follow-on formulae, processed cereal-based foods and baby foods for
infants and young children. The requirements of these Directives are based on two opinions given by
the Scientiﬁc Committee for Food (SCF) on 19 September 19973 and 4 June 1998.4 Because of the
scientiﬁc uncertainty at that time as to the adequacy of existing acceptable daily intake (ADI) values of
pesticides for the protection of health of infants and young children, it was considered appropriate to
adopt, on the basis of the precautionary principle, a very low common limit for all pesticides in these
foods. This very low common limit was ﬁxed at 0.01 mg/kg which was in practice the limit of
quantiﬁcation (LOQ). More severe limitations were set for pesticides or metabolites of pesticides with
an ADI lower that 0.0005 mg/kg body weight per day.
Regulation (EU) No 609/2013 of the European Parliament and of the Council5 requires the
Commission to adopt delegated acts laying down speciﬁc rules for the foods under its scope by 20 July
2015. In this context, the Regulation requires to lay down (and regularly update) rules on pesticides in
foods for infants and young children, taking into account the relevant rules of Directive 2006/125/EC
and Directive 2006/141/EC. These rules should, among others, restrict as much as possible pesticides’
use in the production of infant formula, follow-on formula, processed cereal-based food, baby food
and food for special medical purposes developed to satisfy the nutritional requirements of infants and
young children. In addition, maximum residue levels of pesticides in such foods should be set at the
lowest achievable level to protect vulnerable population groups.6
Preparation of the delegated acts and previous exchanges with EFSA
Taking into account the obligations of Regulation (EU) No 609/2013 described above and, in
particular, the tight deadline for the adoption of delegated acts (20 July 2015), the Commission
requested scientiﬁc assistance to EFSA on 29 October 20147 in accordance with Article 31(1) of
Regulation (EC) No 178/20028. In that request, the Commission explained that it intended to
temporarily maintain the existing approach on pesticides in foods for infants and young children based
on the precautionary principle (default maximum residue limit (MRL)) and to update the outdated lists
of substances originally included in Directive 2006/141/EC and Directive 2006/125/EC for which more
severe limitations applied. EFSA was asked to assess whether the speciﬁc MRLs proposed by the
Commission for these substances at the limit of quantiﬁcation would lead to an exposure not
exceeding the European or internationally agreed ADI taking into account relevant consumption data.
The Commission also explained that it intended, after the adoption of the delegated acts, to require
EFSA to re-evaluate the entire existing approach on pesticides in foods for infants and young children
in the light of scientiﬁc progress.
In its reply of 19 December 2014,9 EFSA accepted the Commission’s request. It noted however that
the approach envisaged by the Commission would not reﬂect the state-of-the art on the matter from a
1 OJ L 339, 6.12.2006, p. 16.
2 OJ L 401, 30.12.2006, p. 1.
3 Scientiﬁc Opinion on a maximum residue limit (MRL) of 0.01 mg/kg for pesticides in foods intended for infants and young
children (1997).
4 Further advice on the Scientiﬁc Opinion on a maximum residue limit (MRL) of 0.01 mg/kg for pesticides in foods intended for
infants and young children (1998).
5 OJ L 181, 29.6.2013, p. 35.
6 During the negotiations on Regulation (EU) No 608/2013, the following statement was made by the Commission: “In
implementing [the rules on pesticides of the Regulation], the Commission will pay particular attention to pesticides containing
active substances, safeners or synergists classiﬁed in accordance with Regulation (EC) No 1272/2008 as mutagen category 1A
or 1B, carcinogen category 1A or 1B, toxic for reproduction category 1A or 1B, or considered to have endocrine disrupting
properties that may cause adverse effects on humans, or which are very toxic, or which cause critical effects such as
developmental neurotoxic or immunotoxic effects, with the objective to ultimately avoid their use”. COM(2013) 241.
7 Ref. Ares(2014)3592505 – 29/10/2014.
8 OJ L31, 1.2.2002, p. 1.
9 Ref. Ares(2015)54901– 8/1/2015.
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scientiﬁc point of view and that a more comprehensive evaluation should be carried out covering a
series of speciﬁc elements. EFSA also explained that, in order to take into account recent food
consumption data that was in the process of being compiled and due to its limited resources, it could
only provide its scientiﬁc assistance by 18 June 2015.
After having analysed EFSA’s comments and considering that EFSA’s proposed timeline was
incompatible with the deadline of 20 July 2015 for the adoption of delegated acts on foods for infants and
young children, the Commission withdrew its request for scientiﬁc assistance with letter of 2 March
2015.10 The existing provisions of Directive 2006/141/EC (which have ensured a sufﬁcient level of
protection of infants so far) were included as such in Commission Delegated Regulation (EU) 2016/127
on these foods that was adopted by the Commission on 25 September in line with Article 11 of
Regulation (EU) No 609/2013. It is however appropriate, at this stage, to require EFSA to start a
comprehensive evaluation on the matter as outlined in the terms of reference below, in view of a future
revision of the rules on the basis of the latest relevant scientiﬁc advice.
1.1.2. Terms of Reference
In accordance with Article 29(1)(a) of Regulation (EC) No 178/2002, the European Commission
asks European Food Safety Authority (EFSA) to provide a comprehensive evaluation of pesticides in
foods for infants and young children by reviewing the relevant SCF opinions of 1997/1998 in the light
of scientiﬁc progress, and provide advice to the Commission on the approach to lay down protective
rules on the matter, taking into account the relevant provisions of Regulation (EU) No 609/2013.
The requested Scientiﬁc Opinion would also proﬁt from the EFSA guidance on the risk assessment of
substances present in food intended for infants below 16 weeks of age (EFSA Scientiﬁc Committee, 2017).
When carrying out its assessment, EFSA should address the speciﬁc points ﬂagged in its letter to
the Commission of 19 December 20149 and cover in particular:
1) The assessment of the appropriateness of the toxicological reference values for pesticides
for infants and young children and of the approach to base the MRLs for pesticides for food
for infants and young children on the ADI values (in this context the assessment of the
short-term dietary risk should also be considered);
2) The assessment of the contribution of other foods consumed by infants and young children
that are not covered by Regulation (EU) No 609/2013;
3) The impact of a cumulative exposure to pesticides which share a common toxicological
effect;
4) The appropriateness of residue deﬁnitions established under Regulation (EU) No 396/2005
for foods for infants and young children.
The experience gained in the assessment of toxicological studies in the framework of the peer
review under Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning
the placing of plant protection products on the market11 (including speciﬁc guidelines developed in
that context) should also be taken into consideration by EFSA for its assessment.
1.2. Interpretation of the Terms of Reference
The EFSA Panel on Plant Protection Products and their Residues (PPR Panel) will develop a Scientiﬁc
Opinion on pesticides in foods for infants and young children. Following further clariﬁcations of the
Commission, the EFSA PPR panel interpreted the Terms of Reference and the speciﬁc tasks as follows:
General considerations
• The opinion should address the appropriateness of the currently established health-based
guidance values (HBGVs: ADI and acute reference dose (ARfD)) for the age groups of infants
and young children given that, in 1997/1998, the SCF had raised doubts about their
applicability for these age groups. The speciﬁc tasks were proposed by EFSA in the reply letter
to the ﬁrst Commission mandate received in October 2014.
10 Ref. Ares(2015)890257– 2/3/2015.
11 OJ L 309, 24.11.2009, p. 1.
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• Different terminologies are used in the legislation12 and by EFSA to deﬁne the two subgroups
of the population under consideration. In the present opinion, the term ‘infants’ refers to the
group 0–1 years of age, while the term ‘young children’ refers to the age group 1–3 years,
also often referred to as ‘toddlers13’. In the current opinion, the term ‘young children’ will be
used, in accordance to the Regulation (EU) No 609/2013.
• All ‘exceptional cases’ will not be considered under this request, such as substances
intentionally added to dietetic food and food for infants and young children as mineral (e.g.
copper compounds), substances already present in the environment or in the food chain (e.g.
CS2, bromide ion, etc.), persistent pesticides such as persistent organic pollutants from
Stockholm Convention but also pesticides with DT90 (soil) > 100 days (e.g. boscalide,
penthiopyrad, etc.). It is noted that analysis of soil is recommended before producing crops
intended to food for infants and young children.
• EFSA PPR Panel recognises that exposure of infants to pesticides via breast feeding, as has
been demonstrated for substances like persistent organic pollutants, could potentially be
signiﬁcant. However, EFSA PPR Panel considered that this issue is outside the scope of the
mandate.
• Apart from chemical pesticide active substances, microbial active substances are also used as
or in plant protection products. These microbial active substances or their secondary
metabolites could remain as residues on edible parts of the plants. It is feasible that these
residues have adverse health effects after consumption. However, since, in general, little
information is available on the toxicology of, and exposure to these degradation products, the
exposure of infants and children to residues from microbial pesticides and their possible
adverse effects will not be addressed in this opinion.
Speciﬁc considerations on the Terms of Reference
In the ﬁrst bullet point of the Terms of Reference (ToR 1), EFSA is requested to assess the
appropriateness of the approach to base the MRLs for pesticides for foods for infants and young
children on the ADI (and if appropriate ARfD) values.
• The Commission clariﬁed that in view of the conclusions of the former SCF (1997, 1998) EFSA
should discuss whether the existing HBGVs set for the general population are appropriate for
infants and young children and if so as from which age, and that EFSA should assess if speciﬁc
HBGVs and/or additional Uncertainty Factors (UF) are necessary for infants and/or young
children (either generally or for any speciﬁc age group).
MRLs at the lowest achievable levels to protect vulnerable population groups
Currently, the default MRL for pesticides in food for infants and young children is 0.01 mg/kg, with
lower MRLs or a ban for some speciﬁc pesticides (Directive 2006/125/EC and Directive 2006/141/EC).
Regulation (EC) 609/2013 requires that the EC has to make provisions (in the future) on the use/
banning of pesticides according to those of Directive 2006/125/EC and 2006/141/EC. According to
recital 21 of Regulation (EU) 609/2013, ‘The maximum residue levels in [infant] food should be set at
the lowest achievable level to protect vulnerable population groups, taking into account good
agricultural practices as well as other sources of exposure, such as environmental contamination.’
The Commission conﬁrms the following:
• the need to set ‘MRL as low as reasonably achievable’ to protect vulnerable population groups,
i.e. if necessary and possible lower than the default MRL of 0.01 mg/kg.
• to let EFSA chose the methodology to check whether:
– current MRLs are safe (particularly default MRLs on foods for infants and young children);
– new MRLs should be derived, and in which case(s);
– real levels of pesticide residues in food (from monitoring programmes) do not present a
risk for the infants and young children.
12 Regulation (EU) No 609/2013.
13 The term ‘toddler’ is used in the EFSA Comprehensive Food Consumption Database; therefore, it will be used to present data
on dietary exposure assessment in Appendix A and Annex A.
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Contribution of other foods
In the second bullet point of the Terms of Reference (ToR 2), EFSA is requested to assess the
contribution of other foods consumed by infants and young children that are not covered by
Regulation (EU) No 609/2013.
• The Commission clariﬁed that the request is about the contribution of each food category
(food for infants and young children and other food, i.e. conventional food) to the total dietary
exposure (chronic and acute) for infants and young children.
• The Commission speciﬁed that approaches/methodologies should be developed for both pre-
and post-marketing assessments, i.e. methods to check if MRLs are sufﬁciently protective for
the consumers but also what the contributors are to the exposure considering monitoring
results.
The Commission conﬁrmed that EFSA can decide which methods are the best to address this task.
Approaches/methodologies should be developed to check the safety of current MRLs of 0.01 mg/kg, of
speciﬁc MRLs from legislation on infants and young children and from MRLs of Regulation (EU)
No 396/2005 on conventional food. Monitoring data should also be used to estimate actual exposure
at post-marketing level. EFSA PPR Panel highlighted the fact that changing the exposure model for
young children could also bring about different results than those currently obtained with the
regulatory exposure model (PRIMo v2).
Impact of cumulative exposure
In the third bullet point of the Terms of Reference (ToR 3), EFSA is requested to address the impact
of a cumulative exposure to pesticides which share a common toxicological effect. In this respect,
EFSA PPR Panel will provide its views on whether the opinions and methodologies it delivered from
2008 to 2013 to support the cumulative risk assessment of pesticides apply to the toxicological effects
which may affect populations of infants and children and the consequences of the application of
cumulative exposure, such as the need for additional UF.
As EFSA PPR Panel is still developing the methodology for cumulative risk assessment, this will not
be completely addressed for the speciﬁc mandate, but indications for the future applicability of the
methodology will be provided in the opinion.
Appropriateness of residue deﬁnitions (RD)
In the fourth bullet point of the Terms of Reference (ToR 4), the Commission requests EFSA to
address the appropriateness of the residue deﬁnitions established under Regulation (EC) No 396/2005
for foods for infants and young children. Regulation (EC) No 396/2005 establishes residue deﬁnitions
suitable for monitoring which are often used for indicative risk assessments on basis of indicator
compound(s) for the pesticide residue. These deﬁnitions are fully appropriate for risk assessment only
when they are identical to the respective residue deﬁnition for risk assessment or, as approximation,
converted by appropriate factors to the toxicological relevant residue comprising additional
compounds.
Commission clariﬁes that:
• currently, diverging residue deﬁnitions have been established for MRLs under Regulation No
(EC) 396/2005 and for MRLs in food for infants and young children due to the fact that the
legislation for infants and young children was not updated in parallel to Regulation (EC)
No 396/2005. EC agreed that it is not necessary to address those residue deﬁnitions one by
one. Hence, Commission expects EFSA to describe whether and in which cases a difference in
residue deﬁnitions between both legislations would be justiﬁed. These approaches and general
considerations could then be applied to substance-speciﬁc assessments in the future. EC also
explained that a Reﬁt exercise of pesticides legislation is currently ongoing which will result in a
report to Council and Parliament in 2019. Once this review is ﬁnalised, steps are foreseen to
align the legislation on infants and young children to Regulation (EC) No 396/2005, in
particular to address the issue of diverging residue deﬁnitions;
• the issue is not limited to foods for infants and young children, since the Regulation (EC)
No 396/2005 also does not foresee speciﬁc residue deﬁnitions for processed food;
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• if relevant metabolites14 are evidenced for processed food for infants and young children,
EFSA should present in the opinion the potential issue and possible recommendations should
be provided (e.g. to decide on the need for a possible follow-up mandate).
Experience gained under Regulation (EU) No 1107/2009
EFSA is requested to take into consideration the experience gained in the assessment of
toxicological studies in the framework of the peer review under Regulation (EU) No 1107/2009 of the
European Parliament and of the Council concerning the placing of plant protection products on the
market (including speciﬁc guidelines developed in that context). EFSA has no speciﬁc experience with
respect to the adequacy for infants and children of the hazard identiﬁcation and characterisation
process for pesticides active substances but will invite Member States to share their experience at
national level through the Pesticides Steering Network.
2. Data and methodologies
2.1. Literature review
Literature searches were performed in Web of Science (http://wok.mimas.ac.uk/) to identify
publications in the public domain in the following areas relevant to the developing infant and young
children:
• Physiology of the gut
• Metabolic and excretory capacities relevant for the elimination of chemicals
• The nervous system, including brain and brain barriers
• The immune system
• The male and female reproductive systems
• The endocrine system
All searches were carried out in English. Comprehensive reviews covering the above areas were
identiﬁed by applying two different protocols for the search of literature on the two subpopulations, as
described in Table 1.
Table 1: Search protocols
Subpopulation
Information
source
Search terms (title) Timespan
Infants Web of
Science
1. ‘intestin*’ OR ‘gastro*’ AND ‘development*’
OR ‘infant’ OR ‘neonat*’;
2. metabolism’ OR ‘cytochrome’ OR ‘CYP*’ OR
‘glucuronidation’ OR ‘glucuronosyl*’ OR
‘sulfation’ OR ‘sulphation’ OR ‘sulfonyl*’ OR
sulphonyl*’ OR ‘acetylation’ OR ‘conjugation’
OR ‘glutathione OR ‘transporter’ or ‘clearance’
OR ‘ADME’ AND ‘development*’ OR ‘infant’ OR
‘neonat*’;
3. ‘brain’ AND ‘development*’ OR ‘infant’ OR
‘neonat*’;
4. ‘immun*’ AND ‘development*’ OR ‘infant’ OR
‘neonat*’;
5. reproduct* OR gonad* OR sexua* OR
endocrin* AND development* OR infant OR
neonat*
May 2016(a)–May 2017
14 OECD (2007), Test No. 507: Nature of the Pesticide Residues in Processed Commodities – High Temperature Hydrolysis,
https://doi.org/10.1787/9789264067431-en
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All titles and abstracts retrieved from the literature search were imported into an EndNoteTM Library
and the duplicates removed.
The abstracts of 1,860 retrieved references found for infants (reviews published in 2016–2017) and
young children (reviews published from 2012 to 2017) were independently screened in parallel by two
members of the WG based on their relevance to the assessment. This was deﬁned by the coverage in
the reference of the developing systems in the infant and young children period. Moreover, a scoring
system was applied to the retrieved references in the EndNoteTM Library to select relevant, not
relevant and possibly relevant references.15 Relevant references identiﬁed for the critical review are
reported in Table 2.
Additional primary references of particular relevance were identiﬁed by the working group
members. Moreover, publicly available guidance documents and reports produced by committees and
international authorities that were relevant to risk assessment of substances in food intended for
infants were considered.
2.2. Occurrence data on pesticide residues
The dietary exposure assessment was based on the occurrence data. In order to assess the
contribution of foods that are intended for infants and young children as well as the contribution of
conventional foods that are not covered by Regulation (EU) No 609/2013, dietary exposure of infants
Subpopulation
Information
source
Search terms (title) Timespan
Young children Web of
Science
1. ‘intestin*’ OR ‘gastro*’ AND ‘development*’
OR ‘child*’ OR ‘toddler*’;
2. ‘metabolism’ OR ‘cytochrome’ OR ‘CYP*’ OR
‘glucuronidation’ OR ‘glucuronosyl*’ OR
‘sulfation’ OR ‘sulphation’ OR ‘sulfonyl*’ OR
sulphonyl*’ OR ‘acetylation’ OR ‘conjugation’
OR ‘glutathione OR ‘transporter’ or ‘clearance’
OR ‘ADME’ AND ‘development*’ OR ‘ontogeny’
OR ‘child*’ OR ‘toddler*’;
3. ‘brain’ AND ‘development*’ OR ‘child*’ OR
‘toddler*’;
4. ‘immun*’ AND ‘development*’ OR ‘child*’ OR
‘toddler*’;
5. ‘reproduct*’ OR ‘gonad*’ OR ‘sexua*’ OR
‘endocrin*’ AND ‘development*’ OR ‘child*’ OR
‘toddler*’
January 2012–May 2017
(a): To update the literature review reported by the Scientiﬁc Committee guidance on the ‘risk assessment of substances present
in food intended for infants below 16 weeks’ (EFSA Scientiﬁc Committee, 2017).
Table 2: Relevant references selected for the developing systems
Subpopulation Developing systems
Relevant references
(from retrieved
references)
Infants Physiology of the gut
Metabolic and excretory capacities relevant for the elimination
of chemicals
Nervous system, including brain and brain barriers
Immune system
Male and female reproductive and endocrine systems
8 (33)
7 (43)
24 (108)
12 (112)
6 (47)
Young children Physiology of the gut
Metabolic and excretory capacities relevant for the elimination
of chemicals
Nervous system, including brain and brain barriers
Immune system
Male and female reproductive and endocrine systems
17 (169)
30 (155)
50 (426)
21 (476)
18 (291)
15 Full text was evaluated for identiﬁed ‘possibly relevant’ references and ﬁnalise the assessment (relevant/not relevant).
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and young children was calculated for ﬁve different case studies reported in Appendix A. The criteria
for selecting those case studies are also reported in the appendix.
Depending on the exposure scenario, two types of occurrence data were used:
• Regulatory data for premarketing scenarios (i.e. results of supervised ﬁeld trials)
• Monitoring data for post-marketing scenarios (i.e. results of the monitoring programmes)
2.2.1. Regulatory data (premarketing)
When a pesticide active substance is evaluated in view of its placing on the market, pesticide
residue concentrations in the raw primary commodities are determined at premarketing level from
supervised ﬁeld trials according to international guidelines (FAO, 2009). Among all pesticide, use
patterns that are intended for authorisation, these supervised ﬁeld trials are designed to reﬂect the use
patterns that lead to the highest possible residues.
In order to assess dietary exposure through conventional foods, available ﬁeld trials are normally
used to derive the following parameters.
• Supervised Trial Median Residue (STMR)
This parameter is the median residue level estimated from the supervised ﬁeld trials. It is used
as an input value to estimate chronic dietary exposure and acute dietary background exposure.
• Highest Residue (HR)
This parameter is the highest measured residue level in the supervised ﬁeld trials. It is used as
an input value to estimate acute dietary exposure through a single food item and is therefore
only derived for active substances where an ARfD is proposed or established.
• Maximum residue levels (MRL)
Where the use of pesticide is intended/authorised and supervised trial median residue (STMR)
or highest residue (HR) values are not available to EFSA, the MRL value is used as a worst-
case input value for both chronic and acute dietary exposure assessment.
• Conversion factor (CF) for risk assessment
Where the residue deﬁnitions for enforcement and risk assessment purposes differ, the CF
refers to the ratio of the residue concentration for risk assessment over the residue
concentration for enforcement. Since the STMR and HR values collected in this framework
refer to the residue deﬁnition for enforcement, STMR and HR values are multiplied by the
appropriate CF (when applicable).
• Peeling factor (PF)
This parameter refers to the ratio of the residue concentration in the peeled commodity over
the residue concentration in the unpeeled commodity and is normally only derived for fruits
and vegetables that are commonly peeled prior to consumption. Since the STMR and HR
values collected in this framework refer to the unpeeled commodity, STMR and HR values are
multiplied by the appropriate PF (when available).
For food intended for infants and young children, occurrence data for premarketing assessment during
approval or authorisation of a pesticide are not available. However, according to Directives 2006/125/EC16
and 2006/141/EC17 repealed by Regulation (EC) No 609/201318, a default MRL of 0.01 mg/kg is
applicable, except for cadusafos, demeton-S-methyl, ethoprophos, ﬁpronil, propineb and their
metabolites for which lower MRLs have been established. In the absence of speciﬁc occurrence data, the
MRL is used for both chronic and acute dietary exposure assessment under the premarketing scenario.
Regarding the ﬁve case studies reported in Appendix A, the parameters reported above were
extracted from EFSA’s reasoned opinions on the review of the existing MRLs prepared under article 12
of Regulation (EC) No 396/2005 (EFSA, 2011c,d, 2013c, 2014a, 2015c) and all subsequent reasoned
opinions prepared under Article 10 or Article 43 of Regulation (EC) No 396/2005 (EFSA, 2011b,e,
16 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and
young children. OJ L 339, 6.12.2006, p. 16–35.
17 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive
1999/21/EC. OJ L 401, 30.12.2006, p. 1–33.
18 Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and
young children, food for special medical purposes and total diet replacement for weight control and repealing Council Directive
92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the
European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009. OJ L181,
29.6.2013, p. 35–56.
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2012a,b,c, 2013a,b, 2014b,c,d, 2015a,b, 2016). In order to ensure consistency with the monitoring
data described in Section 2.2.2, only the reasoned opinions issued before 31 December 2015 were
considered. All relevant parameters (including those at LOQ) were extracted for those pesticide/
commodity combinations where an intended or authorised use was reported to EFSA and where the
MRL proposed by EFSA was legally implemented by the European Commission.
A general overview on the number of reasoned opinions and premarketing data considered for the
assessment of each case study is provided in Table 3. Further details on the occurrence data used for
the premarketing scenario are reported in Annex A – Table 2.
2.2.2. Results from the monitoring programmes (post-marketing)
Regulation (EC) No 396/2005 imposes on Member States the obligation to carry out controls to ensure
that food placed on the market is compliant with MRLs. This regulation establishes both EU-coordinated
control programme (EUCP) and national control programmes (NP). According to Article 31 of Regulation
(EC) No 396/2005, Member States are requested to share the results of these monitoring programmes
and other relevant information with the European Commission, EFSA and other Member States.
Each year, EFSA publishes the EU Report on pesticide residues in food, based on the results of the
latest monitoring programmes. In its report, EFSA analyses the data in view of reporting MRL
compliances and assesses the dietary exposure to pesticide residues and the related risk for European
consumers.
For the ﬁve case studies reported in Appendix A, the results of the 2015 monitoring programmes
(EUCP and NP), detailed in the EU report on pesticide residues in food (EFSA, 2017) were extracted for
the ﬁve pesticides of interest (see Table 4). These data cover more than 296 food products including
291 raw primary commodities and ﬁve food categories intended for infants and young children:
• Infant formulae
• Follow-on formulae
• Processed cereal-based foods for infants and young children
• Baby foods other than processed cereal-based foods
• Food for infants and young children (unspeciﬁed)19
The available data, therefore, allow estimating exposure through each of the above-reported food
categories separately.
Table 3: Overview of the number of reasoned opinions and food items considered for assessment
of the ﬁve case studies under the premarketing scenario
Pesticide
Year of MRL
review(a)
Number of
other reasoned
opinions(b)
Food items
Number of
MRLs
Number of
STMRs
Number of
HRs
Azoxystrobin 2013 1 141 140 n.a.
Deltamethrin 2015 0 142 142 142
Fludioxonil 2011 4 118 118 n.a.
Pyraclostrobin 2011 7 131 130 130
Thiacloprid 2014 2 123 123 123
n.a.: not applicable.
(a): Reasoned opinion on the review of the existing MRLs (prepared under Art. 12 of Regulation (EC) 396/2005).
(b): Number of subsequent reasoned opinions issued before 31 December 2015 (prepared under Art. 10 or Art. 43 of Regulation
(EC) 396/2005).
19 This food category was not considered in the exposure assessment because consumption data were only available for the
speciﬁc food categories mentioned above.
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As indicated in Table 4, results of the monitoring programmes also include a large proportion of left-
censored data (results below the LOQ). In order to estimate the uncertainty related to those left-
censored data, the post-marketing scenario for exposure assessment is further differentiated into a
lower bound (LB) and an upper bound (UB) scenario. While the LB scenario leads to an underestimation
of the exposure since it postulates that samples with results below the LOQ are completely free of the
pertinent pesticide, the UB scenario is a conservative screening which is likely to overestimate the real
exposure, since levels below the LOQ should be set to the LOQ if the pesticide is expected in food.
Hence, in view of performing exposure calculations under the LB and UB post-marketing scenarios,
the following parameters were derived for each active substance and food category of interest.
• Lower bound (LB) mean
The LB mean is the mean residue concentration estimated from the individual sample results,
where each result below the LOQ is set at zero. This parameter is used as an input value to
estimate both chronic dietary exposure and acute dietary background exposure under the LB
scenario. Where regulatory data indicated that the pesticide is not authorised for use on a
given primary commodity (see Section 2.2.1), the LB mean is also used for the UB scenario.
• Upper bound (UB) mean
The UB mean is the mean residue concentration estimated from the individual sample results,
where each result below the LOQ is set at the LOQ. This parameter is used as an input value
to estimate both chronic dietary exposure and dietary background exposure under the UB
scenario, unless regulatory data indicated that the pesticide is not authorised for use on a
given primary commodity (see Section 2.2.1).
• 95th Percentile (P95)
The 95th percentile is estimated from the individual sample results, where each result below
the LOQ is set at the LOQ. This parameter is used as an input value to estimate acute dietary
exposure through a single food item, both under the LB and UB scenarios.
As the samples from the monitoring programmes are normally analysed for the enforcement
residue deﬁnition without peeling, these parameters were multiplied by a peeling factor and CF for risk
assessment when available from the regulatory data (see Section 2.2.1).
Further details on the occurrence data used for both LB and UB post-marketing scenarios are
reported in Annex A – Table 2.
2.3. Consumption data
2.3.1. EFSA Comprehensive Database
The EFSA Comprehensive European Food Consumption Database20 (Comprehensive Database)
provides a compilation of existing national information on food consumption at individual level. It was ﬁrst
built in 2010 (EFSA, 2011a; Huybrechts et al., 2011; Merten et al., 2011) and subsequently updated upon
reception of new dietary surveys from Member States. Details on how the Comprehensive Database is
used are published in the Guidance of EFSA (EFSA, 2011a).
Table 4: Overview of the results from the 2015 monitoring programmes for the ﬁve studied
pesticides (EFSA, 2017)
Pesticide
No food
items
(total)(a)
No
samples
analysed
% positive
samples
(> LOQ)
No baby
food
items(a)
No baby food
samples
analysed
% positive baby
food samples
(> LOQ)
Azoxystrobin 285 63,470 5.6 5 1,232 0.0
Deltamethrin 293 66,026 1.2 5 1,198 0.0
Fludioxonil 274 59,680 6.0 5 1,089 0.09
Pyraclostrobin 275 58,357 1.2 4 1,120 0.0
Thiacloprid 282 59,115 2.8 4 1,119 0.0
Total 296 306,648 4.0 – 5,758 0.0
(a): Food items reported below may have been disregarded from the exposure assessment (and Annex A, Table 2) when
consumption data for that food item were not available.
20 http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb
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Overall, the food consumption data gathered by EFSA in the Comprehensive Database are the most
complete and detailed data currently available in the EU and is already used by EFSA in the other
areas, e.g. chemical contaminants, food and feed additives, and nutrition. Consumption data were
collected using single or repeated 24- or 48-h dietary recalls or dietary records covering from 3 to
7 days per subject.
For the purpose of this assessment, the Comprehensive Database as of 31 March 2018 was used
and only subjects from the following age classes were selected:
• Infants (3–6 months): ≥ 3 months to < 6 months old
• Infants (6–12 months): ≥ 6 months to < 12 months old
• Young children21: ≥ 12 months to < 36 months old
Dietary survey/age class with less than ﬁve consumers were disregarded from the assessment
because such a data set was not considered robust enough to derive any reliable statistics (EFSA,
2011a). Furthermore, when two different dietary surveys were available for one particular country and
age class, only the most recent survey was retained for assessment. Details of the dietary surveys
selected for the current assessment are reported in Annex A – Table 1.
Within the Comprehensive Database consumption data for conventional foods are reported
separately from those speciﬁcally intended for infants and young children. As the occurrence data for
pesticides usually refer to Raw Primary Commodities (RPC), the consumption data for conventional
foods were subject to a draft conversion model which is currently under development in EFSA. This
model disaggregates consumption data for conventional composite foods (e.g. pizza) to primary
ingredients (e.g. wheat ﬂour or tomato puree), which are subsequently converted to the RPC (e.g.
wheat grain or tomato) by means of reverse yield factors. Through this conversion model, a
compilation of RPC consumption data at individual level is obtained where for each consumption event
the corresponding amount of primary commodity is recorded. In order to ensure compatibility with the
available occurrence data, the consumption data obtained were classiﬁed according to Annex I of
Regulation (EC) No 396/2005. It should be noted, however, that the conversion of food consumption
data to RPCs was still under validation at the time of performing the calculation. This uncertainty
should be considered when assessing upper tail exposures obtained with these consumption data.
Regarding foods for infants and young children, consumed amounts were not disaggregated and
retained as consumed, except for powdered infant and follow-on formulae. The latter were converted
to the amount of liquid formulae, assuming that one part of powder is diluted in seven parts of water
(EFSA Scientiﬁc Committee, 2017). These consumption data were then classiﬁed according to the
same food categories as those reported for the post-marketing occurrence data:
• Infant formulae
• Follow-on formulae
• Processed cereal-based foods for infants and young children
• Baby foods other than processed cereal-based foods
2.3.2. Pesticide Residues Intake Model (PRIMo)
The consumption data reported in the Pesticide Residue Intake Model version 2 (PRIMo v2)
currently used in EFSA are detailed in a previous EFSA Opinion (EFSA, 2007a,b). In PRIMo v2, the
reported consumption data were converted to raw primary commodities by the Member States and
reported as edible portion. The chronic consumption data reported in the PRIMo refer to mean
consumption values per survey while the acute consumption data refer to so called ‘large portions’,
which mostly corresponds to the 97.5th percentile of the reported consumptions within a single day
and survey.
It should be noted, however, that PRIMo v2 does not contain any speciﬁc consumption data on
baby foods. Moreover, only four surveys were reported for infants and young children and none is
adequate for infants below 6 months. Although in PRIMo v3 the number of surveys for these age
classes was increased (EFSA, 2018), this latest version of the PRIMo was not yet implemented at the
time of the assessment of the case studies.
21 In the Comprehensive Database this age class is referred to as’toddlers’.
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2.4. Methods for exposure assessment
2.4.1. Exposure assessment for infants below 16 weeks of age
In order to assess exposure of infants below 16 weeks of age to pesticides, the PPR Panel adopted
the recommendation of the EFSA Scientiﬁc Committee to assume a 95th percentile consumption of
infant formula of approximately 260 g/kg body weight (bw) per day, based on 32.5 g/kg bw powder
and 227.5 mL/kg bw water (EFSA Scientiﬁc Committee, 2017). According to the Scientiﬁc Committee,
infants from birth up to 16 weeks are expected to be exclusively fed on breast milk and/or infant
formula. The recommended approach uses the highest reported consumption of infant formula for the
ﬁrst 16 weeks of age as from the period of 14–27 days of life. The consumption pattern over the
2-week period requires the assessment for both acute toxicity and other toxicity endpoints.
For premarketing assessments during approval or authorisation of a pesticide, occurrence data for
infant formula are not available. The default MRL of 0.01 mg/kg for infant formulae (and follow-on
formulae for older age groups) refers to the product as proposed ready for consumption or as
reconstituted according to the instructions of the manufacturer (Article 10 of Directive 2006/141/EC).
The potential contribution of relevant residues present in groundwater used for drinking water
(< 0.1 lg/L,22 equivalent to < 0.000023 mg/kg bw per day) is therefore covered by the existing MRL.
In order to calculate the maximum exposure and to assess the protectiveness of the default value, a
theoretical worst-case exposure was calculated by multiplying the maximum consumption of 260 g/kg
bw per day with the default MRL.
In view of the homogeneous nutrition of infants below 16 weeks by infant formula and the limited
number of analyses, a simple worst-case exposure assessment using maximum intake values and
virtual residues at the MRL level is considered sufﬁcient (cf. premarketing assessment). No post-
marketing exposure analyses are therefore performed.
A reverse exposure calculation for infants below 16 weeks of age is carried out in order to estimate
a trigger value for ADI and ARfD, below which the default MRL of 0.01 mg/kg might not be sufﬁciently
protective. It is noted that in order to ascertain that the HBGVs for a pesticide can be used for infants
under the age of 16 weeks the guidance on risk assessment of substances in food for infants,
published in 2017 (EFSA Scientiﬁc Committee, 2017) should be applied. The ADI is usually the
adequate HBGV to cover both acute toxicity and potential periods of high sensitivity for other toxicity
endpoints. In particular cases, the ARfD with an additional UF (as indicated upon assessment of the
toxicological data package in EFSA Scientiﬁc Committee, 2017) might represent a more conservative
case: however, this factor is not recommended to be used as default.
It should be noted that the use of the MRL as intake value does not explicitly incorporate the
potential occurrence of metabolites. It is, however, assumed that this uncertainty is covered by the
conservative assumption of residues at the MRL level.
2.4.2. Exposure assessment for infants above 16 weeks of age and young
children
Within the regulatory framework of pesticide residues, dietary exposure is normally calculated by
means of the EU PRIMo which uses a fully deterministic methodology (EFSA, 2007a,b). However, to
assess the dietary exposure to pesticides for infants above 16 weeks of age and young children, the
PPR Panel opted for a methodology that is also deterministic but where, unlike the PRIMo, exposure is
calculated for each individual in the consumption surveys. This individual-based approach was
considered more appropriate because it results in a distribution of exposures (rather than a single
exposure estimate) and it accounts for variability within a population (e.g. consumer habits and
bodyweights). This methodology also provides more ﬂexibility because it allows calculating exposure
for any percentile of the exposure distribution that is considered adequate by the risk manager.
Furthermore, the individual-based approach uses consumption data from the Comprehensive
Database. As already discussed in Section 2.3, this database contains data on the consumption of
foods for infants and young children, which is currently only partly available in PRIMo. The
Comprehensive Database also includes a wider range of surveys and a more accurate classiﬁcation by
age class is possible. The individual-based approach is, therefore, expected to better address the
terms of reference as the exposures will no longer be averaged among different age classes.
22 Directive 98/83/EC (EU Drinking Water Directive). OJ L 330, 5.12.1998.
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Regarding the acute exposure calculations, the individual-based approach also allows for the
estimation of both total acute exposure (assuming a background concentration) and acute exposure
per food commodity, while acute exposure in the PRIMo is only calculated per food commodity.
Although processing factors were not included in the current assessment (except peeling), it is
noted that the individual-based model also provides more ﬂexibility compared to PRIMo regarding the
possible incorporation of processing factors for a reﬁned exposure assessment.
Nevertheless, all MRLs that are currently in place for the active substance assessed in Appendix A,
were previously evaluated on the basis of revision 2 of the PRIMo. In order to compare the outcomes
of both methodologies, exposure calculations were also carried out with PRIMo v2.
2.4.2.1. The individual-based approach
When calculating chronic dietary exposure, consumption data and body weight data from the
RPC consumption database were assessed at the individual level. For each individual of the selected
dietary surveys, the average daily consumption of each RPC or infant food category was multiplied by
the occurrence value of the corresponding food item and scenario (see Table 5), and the resulting
exposures per food were summed in order to obtain the total chronic exposure at individual level
(standardised by using the individual body weight). Summary statistics of the individual exposures
were subsequently calculated for all dietary survey and age class combinations. The 95th and the
97.5th percentile exposures were only calculated for survey and age class combinations with more
than 60 and 180 consumers, respectively. Average contributions of the individual foods to the total
chronic exposure were calculated for all individuals within a given survey and age class.
As suggested by the EFSA WG on Food Consumption and Exposure (EFSA, 2011a), dietary surveys
with only 1 day per subject were excluded from the chronic exposure assessment because they are not
adequate to assess repeated exposure. Similarly, subjects who participated only 1 day in the dietary
studies, when the protocol prescribed more reporting days per individual, were also excluded from the
chronic exposure assessment. These exclusion criteria did not apply to the acute exposure assessments.
Acute dietary exposure was calculated by assessing the consumption data at the level of the
single reporting days. Within each individual’s reporting day, the acute exposure was calculated for
each infant food category or primary ingredient expressed in amount of RPC (e.g. wheat ﬂour
expressed in amount of wheat or apple juice expressed in amount of apple). This calculation was
based on the International Estimated Short-Term Intake (IESTI) as it is currently implemented in the
EU (EFSA and RIVM, 2015), although speciﬁc adjustments were needed in order to meet the needs of
the current assessment.
Case 1 (U < 25 g):
IESTI ¼ Cons  Occ
bw
Case 2a (U < Cons):
IESTI ¼ ½U  Occ  v þ ½ðCons  UÞ  Occ
bw
Case 2b (Cons < U):
IESTI ¼ Cons  Occ  v
bw
Case 3 (processed and bulked food):
IESTI ¼ cons  Occ
bw
Where: Cons = Primary ingredient consumed, expressed in amount of raw primary commodity
Occ = Occurrence value selected for the relevant scenario (see Table 5)
bw = individual’s body weight
U = Unit weight of the raw primary commodity (see Annex A – Table 3)
V = variability factor (see Annex A – Table 3)
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In parallel, background exposure resulting from each primary ingredient or infant food category
was calculated by multiplying the amount consumed (expressed in amount of RPC and normalised for
the individual’s body weight) within that day with the relevant occurrence value (see Table 5). Total
dietary exposure for each individual’s reporting day was subsequently calculated by summing the
highest acute exposure observed for a single primary ingredient, and the background exposures for all
other foods consumed within that day. Summary statistics for the total acute exposure were derived
for each survey and age class combination. Contribution of the background exposure to the total acute
exposure within a given survey and age class was calculated for both the full distribution (i.e. all
reporting days) and the upper tail distribution (i.e. reporting days where total acute exposure
exceeded the 95th percentile exposure within that survey and age class). Acute exposure by individual
RPC was calculated by summing the highest acute exposure observed for a single primary ingredient
and the background exposures for other primary ingredients derived from the same RPC and
consumed within that day. In this case, summary statistics of the acute exposure were generated for
each combination of survey, age class and RPC.
For the case studies reported in Appendix A, chronic and acute dietary exposure was assessed
according to different scenarios, comprising premarketing (based on regulatory data) and post-
marketing situations (based on monitoring data). For the post-marketing scenarios, a distinction was
made between an UB and a LB scenario. The selection of the relevant occurrence input value for each
scenario was discussed in Chapter 2.2.2 and is summarised in Table 5. Where applicable, these
occurrence data have been corrected by the use of an additional peeling factor or CF for risk
assessment. The calculated exposures were expressed in percent of ADI or ARfD, respectively, while
contributions of individual foods or background exposures were expressed in percent of total exposure.
In order to assess exposure through the consumption of speciﬁc foods for infants and young
children only, an additional scenario was carried out where all conventional foods were excluded from
the assessment and both the median and maximum occurrence values in all speciﬁc foods were
assumed to be at the default MRL of 0.01 mg/kg. In this case, the exposures were expressed in mg/kg
bw per day (see Chapter 5.3.1).
2.4.2.2. The EU Pesticide Residues Intake Model (PRIMo)
For the premarketing scenario, EFSA also assessed the short-term (acute) and long-term (chronic)
dietary exposure to pesticide residues and the related risk for the EU consumers by using PRIMo v2, and
occurrence values reported in Table 5. Primo v2 is a deterministic model in which single-point estimates
are used for all input data, i.e. occurrence and consumption data. This calculation tool was originally
developed by EFSA for the risk assessment in the context of pesticide authorisations (EFSA, 2007a,b).
The model implements the principles of the WHO methodologies for short-term and long-term risk
assessment (FAO, 2009), based on the food consumption of the European population. The calculations
are generally acknowledged as a conservative risk assessment screening. This PRIMo calculation tool is
available on the EFSA website.
3. The developing infant and young child: physiological and
biochemical considerations
In 2017, the ‘guidance on the risk assessment of substances present in food intended for infants
below 16 weeks of age’ developed by the EFSA Scientiﬁc Committee was published (EFSA Scientiﬁc
Table 5: Selection of the relevant occurrence input value for each exposure scenario
Scenario Data type Chronic exposure
Acute exposure
Single food Background
Premarketing Regulatory STMR(a) HR(b) STMR(a)
Post-marketing (LB) Monitoring LB mean P95 LB mean
Post-marketing (UB) Monitoring UB mean(c) P95 UB mean(c)
HR: highest residue; LB: lower bound; STMR: supervised trial median residue; UB: upper bound; P95: 95th percentile.
(a): Where the STMR is missing, the EU Maximum Residue Level is used instead.
(b): As some of the occurrence data referred to post-harvest treatments, it was decided to use the HR in all IESTI equations
(including the case 3 calculations). Furthermore, where the HR is missing, the EU Maximum Residue Level is used instead.
(c): Where a pesticide is not authorised for use on a given commodity, the LB mean is used instead.
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Committee, 2017). Although the guidance addresses speciﬁcally the risk assessment of infants less
than 16 weeks of age, the description of physiological development also largely covers infants and
young children above 16 weeks of age. For the present opinion, an additional literature search was
performed to identify new publications since 2017 and also publications addressing the speciﬁc
development various subgroups of infants and young children (see Section 2.1). Although the search
yielded some new relevant studies, in particular for the nervous system, the ﬁndings were in line with
those described by the EFSA Scientiﬁc Committee (2017). Below a summary of the evaluation of the
physiological development of infants and young children is presented. Additional information on the
developing nervous system, not described in the guidance of the Scientiﬁc Committee is presented in
Appendix B.
Generally, the major physiological differences between infants and children as compared to adults
are observed in the ﬁrst weeks after birth, in particular in preterm neonates (WHO, 2006). Maturation
of organs and systems occurs at different rates. Some parameters, e.g. certain cytochrome P450
isoforms, reach adult levels within weeks up to months, whereas other functions, organs and
physiological systems, such as the brain and the immune system take several years or even decades
to reach maturity (EMA, 2009; Pettengill et al., 2014; de Wildt et al., 2014; He et al., 2016).
The development of organs and systems affecting the TK of chemical substances is well studied. At
birth, gastric, pancreatic and biliary functions are not fully mature and the absorption of substances in
general might be slower, although the amount absorbed is not dependent on the age (Zoppi et al.,
1972; Menard et al., 1995; Kearns et al., 2003).
Infants and children have a higher intake of drinking water consumption per kilogramme of body
weight. This is estimated to be 1 L of water/day for a 10 kg child against a lifetime average ﬁgure of 2
L per day for a 70 kg adult (USA EPA, 2012). This has been taken into account in risk assessment of
sub chronic studies. The distribution of the substance may be different from that in adults due to, for
instance, differences in body composition, regional blood ﬂow, organ perfusion and cardiac output and
plasma protein-binding capacity between infants and adults (Fredholm et al., 1975; Windorfer et al.,
1978; Friis-Hansen, 1983; Mielke and Gundert-Remy, 2009). The capacity of enzymes involved in
phases I and II metabolism is generally up to two- (full term) to threefold (preterm) lower when
comparing infants with healthy adults. Likewise, renal function is also reduced at birth and its function
increases in the ﬁrst year of life.
The maturation of the nervous, skeletal and the immune system in children continues well into their
teens, although various immune parameters reach adult levels at different rates.
Contrary to previous assumptions, the healthy blood–brain barrier (BBB) in the ﬁrst 16 weeks,
although immature, is considered functional and not leaky (Saunders et al., 2014). However, the
expression/activity of transporters and metabolising enzymes appears to vary from adult patterns to
meet the needs of the developing brain and apparently give rise to the measured differences in uptake
and metabolism rates across the neonatal and infant BBB (Ek et al., 2012; Mann et al., 2016). The
developing immune system in foetal and early postnatal life is particularly sensitive to immunotoxicants
(DeWitt et al., 2012, Kollmann et al., 2012; Krishnamoorthy et al., 2012). Neonates have speciﬁc
features in the development and maturation of their immune system, which make their response to an
immunogenic/allergenic compound different from that of an adult and therefore, deserve speciﬁc
studies. The development of the female reproductive system in infants below 16 weeks of age is
relatively quiescent (Neal-Kluever et al., 2014). For the development of the male reproductive organ
the testis, however, this is a sensitive period (Camatini et al., 1981; Lemasters et al., 2000). Effects on
the development of the reproductive organs generally become apparent later in life. Infants below 16
weeks of age have speciﬁc endocrine proﬁles that are different from those in adults (Grumbach, 2002;
Kuiri-H€anninen et al., 2014).
Thus, effects on the nervous, immune, reproductive, and endocrine systems as well as skeletal
system at any early developmental stage may be reﬂected in deﬁcits at later time points, indicating
that the window of exposure, the window of maximum sensitivity and the window of effect require a
lifespan approach to generate a fully protective risk assessment.
In infants older than 16 weeks generally, the expression of metabolising enzymes and the renal
excretion approaches adult levels. Furthermore, although the maturation of the organ systems in
infants above the age of 16 weeks and children may continue well into their teens, the available
information indicates that the differences between these age groups and adults are rather limited.
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3.1. Appropriateness of animal models and recommendations
The recently adopted Guidance on the risk assessment of substances present in food intended for
infants below 16 weeks of age (EFSA Scientiﬁc Committee, 2017) speciﬁcally addresses the testing of
the developing immune and nervous system in regulatory animal studies. The discussion of the animal
models is not strictly limited to the age below 16 weeks. Further general elaborations can be found in
Felter et al., 2015.
The WHO (2006) provides an elaborate comparison between humans and animal test species.
Since the standard requirement for pesticides is studies in rodents and nearly always in rats, this will
only be discussed below. The reproductive/developmental neurotoxicity (DNT) studies available for
pesticides cover at least the period until weaning which is roughly equivalent to the age of 3 years in
humans.
To address this period of exposure, according to the data requirements as a minimum (EU, 201323),
the two-generation reproduction toxicity study (OECD TG 416) is available. Alternatively, the extended
one-generation reproductive (EOGRTS; OECD TG 443) may be considered. As observed in guidance on
the risk assessment of substances in food intended for infants below the 16 weeks of age (EFSA Scientiﬁc
Committee, 2017), the EOGRTS with the DNT and developmental immuno toxicity (DIT) cohorts and the
DNT study (OECD TG 426) are the only studies that speciﬁcally address the postnatal period and this also
includes periods similar to the age of 3. However, these two tests (DNT and DIT) are not mandatory for
pesticides and are only triggered by observations of neurotoxicity (NT) or immunotoxicity (IT) in other
toxicity studies. The EOGRTS including the DNT cohort may be considered as an alternative to
development and reproduction studies in rats and could be required for speciﬁcally addressing DIT, DNT
and endocrine disruptive properties. The DNT TG 426 is triggered when there are signs of adult NT, when
the pesticide has a neurotoxic pesticidal mode of action, or if it shares structural similarities to a
substance with known DNT properties.
Recent analysis24 of the availability of such studies in pesticide risk assessment particular covering
the infant period showed that out of the 485 pesticides approved in Europe, only 35 had DNT studies.
Moreover, status is that the EOGRTS has been provided only in very few cases, in particular for
pesticides undergoing renewal. The lack of EOGRTS with the DIT/DNT is clearly considered an
uncertainty in many regards.
However, in the future, it can be foreseen that the EOGRTS probably would be available in more
cases since this study might be triggered in regard to assessing the endocrine disruptive properties of
pesticides according to the draft guidance for the identiﬁcation of endocrine disruptors in the context
of Regulation (EU) No 528/2012 and (EC) No 1107/2009. The criteria for identifying the endocrine
disruptors require an endocrine mode of action as well as an adverse effect. Hence, for many of the
oestrogen-, androgen-, thyroid- and steroidogenesis-mediated effects, the EOGRTS will be required to
detect the adverse effect.
Regarding identifying DNT properties, it has been recommended that in vitro methods should be
developed (EFSA PPR Panel, 2013a,b,c; Fritsche et al., 2017; OECD, 2017). There is consensus that
such in vitro assays should cover key processes (neuronal proliferation, migration, differentiation,
synaptogenesis, myelin formation and neuronal network formation and function) during the
development of the nervous system and should be conducted with all relevant cell types (neurons and
glial cells). Recently, the OECD has taken up this activity and will develop a complementary guidance
for interpreting and integrating such data into regulatory decision making.
However, as acknowledged, the current DNT (OECD TG 426) protocol has limitations and
uncertainties, in particular in regard to sensitivity, reproducibility, relevance of extrapolation from
rodent to humans due to kinetics, timing in brain development, use of non-homologues functional test
and that rodents do not capture relevant human diseases like autism/ADHD.
Overall, it should be recommended in the future to (1) screen all pesticides for DNT properties in
DNT testing battery, (2) review and improve the DNT (OECD TG 426) and (3) if a reproductive study is
to be performed, it should be the EOGRTS with DIT and DNT cohorts (OECD TG 443).
23 Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in
accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant
protection products on the market, OJ L 93, 3.4.2013, pp. 1–84.
24 OECD/EFSA Workshop on Developmental Neurotoxicity (DNT): the use of non-animal test methods for regulatory purposes
(https://www.efsa.europa.eu/it/events/event/161018b).
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4. The assessment of the appropriateness of the toxicological
reference values for pesticides for infants and young children and of
the approach to base the MRLs for pesticides for food for infants
and young children on the ADI values (ToR1)
4.1. Approach for ADI and ARfD setting for pesticides in infants and
young children
It has long been recognised that HBGVs such as the ADI and ARfD do not apply to very young
infants (i.e. up to the age of 12–16 weeks). At the request from the European Commission to the
European Food Safety Authority (EFSA), EFSA’s Scientiﬁc Committee prepared a guidance for the risk
assessment of substances present in food intended for infants below 16 weeks of age (EFSA Scientiﬁc
Committee, 2017). The cut-off of 16 weeks was among others based on the physiological immaturity
of many of the organ systems in the ﬁrst weeks and hence an enhanced vulnerability, nutrition habits
up to that age (i.e. mother’s milk or infant formulae intended for use as the sole source of nutrition)
and since the standard animal testing currently used to assess the toxicity of chemicals do not address
this speciﬁc age group. In the EFSA Scientiﬁc Committee guidance (2017), for substances intentionally
added to food, it was recommended to require the EOGRTS if the substance is systemically available,
or a neonatal animal study if the substance is not absorbed from the gastrointestinal tract and is not
systemically available. If effects are seen with a no observed adverse effect level (NOAEL) below the
NOAEL of standard testing results, then this NOAEL will be used to derive the HBGV.
Usually an intraspecies factor of 10 is applied to take the increased vulnerability of sensitive human
populations such as infants and children into account. The factor of 10 is generally accepted as being
adequate. However, because of reduced activity of most metabolic enzymes, the overall impact on the
clearance and half-life of substances (decrease in clearance, increase in half-life) is up to two- (full-term)
to threefold (preterm) lower when comparing infants below the age of 16 weeks with healthy adults. In
addition, the renal function (glomerular ﬁltration rate, tubular reabsorption) is reduced in the ﬁrst weeks
and months resulting in a reduced excretion of substances excreted by the kidney. Hence, the guidance
recommends an additional assessment factor for substances not intentionally added to food for infants
below 16 weeks of age. If no speciﬁc information on the substance is available, the guidance
recommends using an additional factor of 3.
The question remains whether infants above 16 weeks of age and children are adequately protected
by the ADI and ARfD. As discussed above, the development of organs and systems in infants and
children continues well after 4 months, and for certain parameters, adult levels are only reached after
several years. However, the differences between infants above 16 weeks of age and young children are
rather limited as compared to adults. Concerning the metabolism of xenobiotics, the information which is
available indicates that no major differences exist in the age group above 2–4 months (Edginton et al.,
2006; de Wildt, 2011; Saghir et al., 2012; Valcke and Krishnan, 2013). In order to further estimate the
relative susceptibility to the effects of chemicals of infants and young children as compared to adults, for
the present opinion, an inventory was made of the therapeutic doses of pharmaceuticals that are used
to treat infants and children as well as adults (see Appendix C for details). Recommended oral doses of
82 medicines used for treatment of infants and young children between about 4 months and up to 3
years of age were compared to the oral doses of these medicines used in adults and the ratio of the
doses, expressed as mg/kg bw per day, was calculated. For these 82 medicines, the ratio of the doses in
adults to those in infants and young children was 0.95 with a range of 0.23–3.8. This indicates that the
mean dose in infants and young children is the same as in adults. The highest value of the ratio of 3.8
means that the dose in adults is 3.8-fold higher than in the infants and young children, indicating a
higher sensitivity in this age group for this particular medicine. It is noted that among the medicines
available on the European market, there are some medicines which are contraindicated in infants and
young children. In many cases, the contraindication is due to regulatory formalities and is toxicologically
not relevant. Otherwise, contraindications for this age group are based on speciﬁc toxicological ﬁndings,
only relevant for the age group of infants (e.g. chinolons). As the testing requirements for pesticides are
as strict as the testing requirements for medicines, if approval for this age group is sought, it is expected
that age speciﬁcities are detected by the required testing.
As the dose of a medicine considers and encompasses kinetic differences as well as dynamic
differences, the factor of 3.8 as the greatest difference found in the database is well within the default
uncertainty factor of 10 (kinetic plus dynamic) used to account for differences in intraspecies
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susceptibility. Based on the observation that the differences between infants above 16 weeks of age
and young children as compared to adults are rather limited, as illustrated by an analysis of the
metabolic pathways and an additional analysis of the ratios of therapeutic doses of medicines, it was
concluded that the ADI and ARfD can be applied to infants above 16 weeks of age and young children,
and that an additional assessment factor is not necessary for these age groups.
The guidance document on the risk assessment of substances present in food intended for infants
below 16 weeks of age (EFSA Scientiﬁc Committee, 2017) establishes that the EOGRTS with DNT/DIT
cohorts or, if justiﬁed the two-generation reproductive toxicity study (OECD TG 416) with postnatal
studies including IT and NT investigations, should be provided for substances intentionally added to food
for infants. For approved pesticides in EU, there would be data equivalent to EOGRTS (i.e. current OECD
TG 416 protocol would be adequate but older protocols not) and postnatal studies are only triggered by
signals (NT/IT) in other studies conducted in adult animals. These data are always taken into account
when establishing the ADI and ARfD with the standard UFs accounting for inter- and intraspecies
differences. Therefore, in conclusion, the already established approach for setting ADI and ARfD is
appropriate for infants above 16 weeks of age and young children (see case studies in Appendix A). For
infants below 16 weeks of age, the current approach for setting ADI and ARfD may not be appropriate
and the application of the EFSA guidance on risk assessment of substances in food for infants (EFSA
Scientiﬁc Committee, 2017) is recommended.
4.2. Appropriateness of the approach to base the MRLs for pesticides for
food for infant and young children on the ADI (and if appropriate
ARfD) values
In order to guarantee the consumer safety of MRLs in food (and infant food in particular), a risk
assessment for all MRLs is generally necessary based on maximum expected levels of residue intake
and appropriate toxicological reference values.
For infant food, a standard level of 0.01 mg/kg (based on the validated LOQ level for the
monitoring residue deﬁnition) is set as regulatory standard. Where the residue intake at such levels
does not allow to conclude on an acceptable dietary intake below the established HBGVs, an
appropriate lower LOQ of the analytical method needs to be available for risk assessment and to
survey the safety of food speciﬁcally dedicated to children.
The approach to base MRLs for pesticides for foods for infants and young children on the HBGVs is
considered as appropriate, where the default MRL (standard LOQ of 0.01 mg/kg) is not indicating a safe
level of dietary intake. For this approach, it is recommended to apply the monitoring residue deﬁnitions
as harmonised to Regulation (EU) No 396/2005 for both monitoring and indicative risk assessment.
5. Dietary exposure of infants and young children to pesticide residues
(ToR2)
5.1. Characteristics of food consumption by infants and young children
During the ﬁrst years of life dietary patterns change rapidly, more than at any other period later in
life. This may implicate challenges and uncertainties for a precise and valid food consumption
assessment to be used as a basis for exposure calculations to substances in food. Basically, food
diversity increases from essentially exclusive milk feeding in the ﬁrst months of life to a more and more
varied food selection starting with the introduction of complementary food which is recommended not to
start before the age of 4 months (EFSA NDA Panel, 2009; EFSA Scientiﬁc Committee, 2017; Fewtrell
et al., 2017) and is followed by a gradual transition to family food around the end of the ﬁrst year of life.
5.1.1. Introduction of complementary feeding
In practice, infants are sometimes not fed in line with the recommendations of EFSA (EFSA NDA
Panel, 2009). They may thus be exposed to food other than milk, i.e. complementary food, well before
the age of 4 months. Indeed, consumption of complementary food already at an age of 3 months was
reported in up to 30% of formula fed infants and up to 8% in breastfed infants on average in ﬁve
European countries (Schiess et al., 2010). Moreover, infant feeding practices differ across European
countries (Schiess et al., 2010; de Lauzon-Guillain et al., 2013). Untimely introduction of
complementary feeding even before the age of 3 months occurred 0twice as often in English and French
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cohorts as in Greek and Portuguese cohorts (10% vs. < 5%). In the majority of infants per cohort,
complementary feeding was introduced in England between 3 and 4 months of age, in the Netherlands
at 4 months and in Greece at 5 months (de Lauzon-Guillain et al., 2013).
As to the type of complementary food used, commercial complementary food products were more
popular in formula fed infants than in breast fed infants throughout the complementary feeding period
(Schiess et al., 2010).
5.1.2. Interindividual variability in eating skills
Attainment of speciﬁc eating skills may impact on what types of food parents offer to the child.
There is considerable variation in the ages at which infants and young children achieve new feeding
skills depending on differences in their psychomotor development, interaction with the environment
and how often these skills are promoted by their parents. For instance, the mean age at which infants
use the tongue to move food to the back of the tongue to swallow was observed as 4.95 months, with
a standard deviation of 1.27 months and a range of 2.0–7.5 months (Carruth and Skinner, 2002).
Similar interindividual variations are observable in eating capabilities in older infants and young
children, for instance a median (10, 90th percentile) age of around 9 (11, 17) months for holding the
bottle and of around 17 (13, 18) months for self-feeding with a spoon (Largo, 2008).
5.1.3. Selective food intake
During the course of decreasing energy requirements (per kg bw) in the second year of life,
children often show a decrease in appetite and get selective and erratic in their food choice, so-called
‘fuzzy’ or ‘picky’ eating. The terms are generally used to characterise children who eat a limited
amount of food, have strong food preferences, a low-dietary variety and restricted intake particularly
of vegetables and fruit. Picky/fuzzy eating is usually a temporal behaviour and does not have a
signiﬁcant effect on growth (Mascola et al., 2010; Cardona Cano et al., 2015).
Food neophobia, the avoidance of new foods, is a distinct but related characteristic of young
children’s dietary habits, associated with a low vegetable and fruit acceptance as well (Harris and
Mason, 2017). Even foods that have been accepted prior to the onset of the neophobic stage might be
refused if their appearance changes on subsequent presentations. It is thought that food neophobia is
an evolutionary defence against the possibility of ingesting poisons by consuming unknown
substances.
Food fussiness and food neophobia both show considerable heritability, but shared environmental
factors, for example, the home environment, are of greater inﬂuence on interindividual differences in
their expression (Smith et al., 2017).
Unfortunately, due to a missing uniform deﬁnition and due to differences in data collection in the
existing studies, no deﬁnite data on occurrence of selective food intake in young children can be given
(Taylor et al., 2015).
5.1.4. Food consumption assessment
Assessment of dietary intake in infants and young children is especially challenging, requires special
methodology to consider age-speciﬁc food consumption habits and is further complicated by the rapid
growth changes that occur during a relatively short period of time. Not all food served to an infant or
young child is necessarily consumed, some may be wasted. This is expected to lead to overestimations
of exposure. If the child attends day care, adults other than the parents may be involved in dietary
assessment (Gondolf et al., 2012).
Nevertheless, misreporting in the form of underreporting of energy intake which is a common
phenomenon in dietary assessments is much less frequent in young children than for instance in
female adolescents (1% vs. 20%) (Sichert-Hellert et al., 1998) or in another study in 3–10-year-old
children and adolescents aged 11–17 years (4.9% vs. 26.0%) (Lioret et al., 2011).
Diet records over several days have been proven to be a valuable tool for measuring energy and
food intake in infants in the second half of the ﬁrst year of life and young children when compared to
total energy expenditure. Repeated 24-h recalls are suggested to be the most accurate method to
estimate total energy intake in children aged 4–11 years (Burrows et al., 2010; Gondolf et al., 2012).
In both methods, parents need to be instructed how to quantify food consumption and consider
leftovers. Fewer days are needed for reasonably accurate dietary assessments in infants and young
children as compared with adults and older children (Lanigan et al., 2004).
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5.1.5. Conclusions
Based on the ﬁndings above, the EFSA PPR Panel concluded that exposure assessment for the
following age classes should be performed:
• infants below 16 weeks of age
• infants from 3 to 6 months
• infants from 6 to 12 months
• young children (or toddlers; from 12 to 36 months).
As infants below 16 weeks of age will be expected to be exclusively fed on breast milk and/or
infant formula, the exposure assessment for this age class can be carried out according to the
recommendations of the EFSA Scientiﬁc Committee (see Section 5.2). For older infants and young
children, exposure assessment can be carried out on the basis of the dietary surveys included in the
EFSA Comprehensive Database (see Section 2.3.1). These surveys were carried out using either a
dietary record or a 24 h-recall method, which are considered appropriate for assessing food
consumption in infants and young children.
The EFSA PPR Panel noted the overlap between infants below 16 weeks of age and infants from 3
to 6 months. This overlap was considered acceptable as it addresses uncertainty regarding infants that
are exposed early to complementary feeding at the age of 3 months (see Section 5.1.1).
5.2. Exposure of infants below 16 weeks of age
The residue intake via ready-to-feed milk during the peak consumption period 2–4 weeks after birth
(260 g/kg bw per day; EFSA Scientiﬁc Committee, 2017) containing residues at the maximum level of
0.01 mg/kg is calculated as 0.0026 mg/kg bw per day. The higher residue intake compared to the
calculation of the SCF (0.0005 mg/kg bw per day; SCF, 1997) is mainly caused by the commodity to
which the MRL applies milk after reconstitution in the current Scientiﬁc Opinion (according to Article 10
of Directive 2006/141/EC) vs. milk powder before reconstitution in SCF opinion (SCF, 1997).
It is concluded that the default MRL of 0.01 mg/kg for infant formulae does not result in an
unacceptable exposure to infants for all compounds to which a HBGV of 0.0026 mg/kg bw per day or
higher applies after application of the guidance on risk assessment of substances in food for infants
(EFSA Scientiﬁc Committee, 2017). Lower MRLs, however, are recommended for active substances
with HBGV for infants below 0.0026 mg/kg bw per day.
For the ﬁve case studies reported in Appendix A, the HBGVs were above the value 0.0026 mg/kg
bw per day and the default MRL of 0.01 mg/kg for infant formula is considered sufﬁciently protective
for these substances. The consumer safety of the threshold of 0.0026 mg/kg bw per day is connected
with uncertainties as regards the pesticide-speciﬁc degradation under processing conditions, the
potential relevance of metabolites and the composition of the formula.
It is, therefore, recommended to perform a dietary risk assessment for foods intended for infants
and young children during a regulated procedure.
5.3. Exposure of infants above 16 weeks of age and young children
For assessing exposure of infants above 16 weeks of age and young children, the EFSA PPR
Panel evaluated a new methodology (see Section 2.4.2.1) by means of several case studies reported in
Appendix A that studied age classes 3–6 months, 6–12 month and 12–36 months (young children).
In the Appendix A, both the 95th and the 97.5th percentile exposures are presented, but it is noted
that, in other regulatory frameworks, the 95th percentile is the most frequently used reference point
(e.g. chemical contaminants and food and feed additives).
In general, exposures were found to be the highest for young children and the lowest for infants
from 3 to 6 months of age (although some exceptions were also identiﬁed). This increase of exposure
with age is correlated to the increasing consumption of conventional foods, which was the main source
of exposure in all case studies. The contribution of speciﬁc foods for infants and young children to the
overall exposure was low.
5.3.1. Contribution of foods intended for infants and young children
For the ﬁve case studies reported in Appendix A, assuming that all foods speciﬁcally dedicated to
infants and young children (including infant and follow-on formulae) contain residues at the maximum
level of 0.01 mg/kg, contribution of these food items mostly represented less than 5% of the total
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chronic exposure. For cereal-based foods and infant formulae, however, these contributions may go up
to around 50% in certain surveys, in particular for infants between 3 and 6 months of age. This
ﬁnding is consistent with the expectation that some infants within this age class will still be fed mainly
with infant formulae.
The highest contributions, however, were usually identiﬁed for the surveys with the lowest total
exposures. Furthermore, when exposure through foods for infants and young children is calculated in
absolute amounts, the mean chronic exposure of infants between 3 and 6 months ranges from 0.0005
to 0.0008 mg/kg bw per day. Total acute exposure (95th percentile) for this age class is estimated to
be between 0.0014 and 0.0020 mg/kg bw which is in any case lower than the exposure calculated for
infants below 16 weeks of age. Hence, any default MRL derived for infants below 16 weeks of age
(based on the consumption of infant formula, see Section 5.2), will also provide adequate protection
as regards the exposure of other infants and young children through the consumption of all speciﬁcally
designed foods.
Table 6: Summary statistics of total chronic dietary exposure across European dietary surveys when
assuming a default MRL of 0.01 mg/kg in all infant food categories (excluding conventional
foods)
Level of exposure(a) Age class N
Total chronic dietary exposure
(mg/kg bw per day)
Minimum Median Maximum
Mean Infants (3–6 months) 3 0.0005 0.0008 0.0008
Infants (6–12 months) 6 0.0003 0.0005 0.0006
Toddlers 10 0.0000 0.0001 0.0004
95th percentile Infants (3–6 months) 2 0.0014 0.0017 0.0020
Infants (6–12 months) 5 0.0009 0.0011 0.0012
Toddlers 6 0.0002 0.0005 0.0008
97.5th percentile Infants (3–6 months) 1 0.0020 0.0020 0.0020
Infants (6–12 months) 4 0.0011 0.0012 0.0012
Toddlers 2 0.0009 0.0009 0.0009
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table 7: Summary statistics of total acute dietary exposure across European dietary surveys when
assuming a default MRL of 0.01 mg/kg in all infant food categories (excluding conventional
foods)
Level of exposure(a) Age class N
Total acute dietary exposure
(mg/kg bw)
Minimum Median Maximum
Mean Infants (3–6 months) 3 0.0006 0.0008 0.0009
Infants (6–12 months) 6 0.0004 0.0005 0.0006
Toddlers 10 0.0001 0.0002 0.0004
95th percentile Infants (3–6 months) 3 0.0014 0.0015 0.0020
Infants (6–12 months) 5 0.0010 0.0011 0.0012
Toddlers 8 0.0002 0.0006 0.0008
97.5th percentile Infants (3–6 months) 3 0.0015 0.0016 0.0021
Infants (6–12 months) 5 0.0011 0.0012 0.0013
Toddlers 5 0.0003 0.0009 0.0010
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations
respectively may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
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5.3.2. Contribution of conventional foods
Within the group of conventional foods, the commodities driving the exposures will be very
dependent on the use pattern of the pesticide under assessment. Typically, chronic exposure will
mainly be driven by the most frequently consumed food commodities (e.g. potatoes, cereals, citrus
fruits and pome fruits) whereas acute exposure may also be driven by less frequently consumed foods
and seasonal products (e.g. peaches, table grapes etc.). While cereals were found to be the main
drivers for the exposure to deltamethrin, exposure to the other pesticides investigated was mainly
driven by fruits and potatoes. It should be noted, however, that some of these contributors are either
consumed peeled (e.g. citrus fruits) or processed (e.g. cereals). If data on the effect of processing
would be readily available, a more reﬁned exposure calculation could be carried out for these food
items and their actual contribution to the exposure is likely to be much lower.
5.3.3. Other considerations
Another important ﬁnding is the large difference between exposures calculated from premarketing
and post-marketing data. Premarketing scenarios have the implicit assumption that all foods were
treated according to the most critical authorised uses for a given pesticide (i.e. conditions of use
assumed for deriving the MRLs in conventional foods). The available post-marketing data show,
however, that pesticide concentrations in food are generally lower than those anticipated from the
premarketing data, hereby resulting in a lower exposure for the post-marketing scenario. The
magnitude of this difference between premarketing and post-marketing exposure is again very much
depending on the use pattern of a compound. Among the ﬁve case studies investigated, the smallest
difference was observed for deltamethrin and thiacloprid (two to ﬁvefold difference) and the largest
difference was observed for azoxystrobin (10- to 100-fold difference). Post-marketing assessments
have additional uncertainty associated to the high proportion of left-censored data (reﬂected by the
differences between the LB and UB results), which is also varying signiﬁcantly depending on the active
substance assessed. Hence, while it is very likely that actual exposure calculated from post-marketing
data will be lower than the exposure anticipated from premarketing data, it is not possible to predict
the magnitude of this difference.
Calculations reported in Appendix A also show that exposure estimates obtained through the
individual-based approach (IBA) are higher than those obtained with PRIMo v2. From the 655 MRLs
assessed in Appendix A, exceedances of the ARfD were identiﬁed for 14 MRLs that have not been
identiﬁed with PRIMo v2 for these MRLs. Furthermore, while the mean chronic exposure estimates
obtained with the new methodology are in the same range as chronic exposure estimates obtained
with PRIMo v2, the new method also allows calculating exposures for different percentiles of the
chronic exposure distribution, which may be of interest for risk managers. The main reasons for these
differences were already discussed in Sections 2.3.2 and 2.4.2. Meanwhile, these outcomes should be
considered with caution because the conversion of EFSA’s Comprehensive Database into consumption
data for raw primary commodities is still under validation and exposure calculations might still be
reﬁned by means of processing factors. It would therefore at this stage not be appropriate to take any
MRL-speciﬁc measures on the basis of the current calculations. These ﬁgures are mainly intended to
provide risk managers with an idea on how the individual-based methodology compares to the
reference method that is currently in place for exposure assessment in the area of pesticides.
6. Impact of cumulative exposure (ToR3)
Regulation (EC) No 396/2005 on MRLs provides that decisions on applications concerning MRLs of
pesticides must take account of their cumulative and synergistic effects when methodologies to do so
will be available.
In 2006, EFSA organised a Scientiﬁc Colloquium on the topic where more than 100 experts
evaluated the state of knowledge in the ﬁeld and proposed a strategy for implementation of cumulative
risk assessment for Pesticides in Europe.25 Key conclusions of this international event were that
• a methodology should be developed starting from already existing approaches,
• criteria for grouping substances and a guidance for probabilistic exposure modelling needed to
be conceived and that
25 The EFSAs 7th Scientiﬁc Colloquium Report - Cumulative Risk Assessment of pesticides to human health: The Way forward:
https://www.efsa.europa.eu/it/supporting/pub/117e
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• EFSA PPR Panel should be tasked with these activities.
As recommended, the EFSA PPR Panel initiated a programme of activities to develop the needed
methodologies.
In 2008, a ﬁrst Scientiﬁc Opinion was adopted, evaluating the suitability of existing methodologies
to assess cumulative and synergistic risks from pesticides to human health with a view to set MRLs for
those pesticides in the frame of Regulation (EC) 396/2005 (EFSA PPR Panel, 2008). In this opinion, the
three main forms of combined toxicity of chemicals were reviewed:
• Dose addition (also referred to as similar action), which takes place where chemicals in a
mixture act in the same way, by the same mechanism/mode of action and differ only in their
potencies;
• Response addition (also referred to as dissimilar action), which takes place where the modes of
action and possibly, but not necessarily, the nature and sites of toxic effects differ between the
chemicals in a mixture, and one chemical does not inﬂuence the toxicity of another;
• Interaction, which embraces all forms of joint action that deviates from the two classes of
combined toxicity described above. This includes for example synergistic, potentiating,
antagonistic, inhibitive effects.
The main conclusion of the Panel was that only the ﬁrst of these forms of combined toxicity had a
major relevance for pesticides, because their residues are present in food at very low concentrations.
However, the panel noted that certain endocrine disruptors showed dose additivity even when they do
not share the same primary molecular target. An issue was, therefore, identiﬁed with respect to the
concept of common mechanism/mode of action and the Panel suggested considering the commonality
of a phenomenological effect as a criterion for grouping chemicals.
As it considered dose addition as the most relevant form of combined toxicity, the Panel reviewed
the existing methods characterising cumulative risks based on this principle. These methods include
calculations of (adjusted) hazard indexes, reference point indexes, combined margins of exposure,
cumulative risk indexes or require ﬁrst the identiﬁcation of an index compounds and normalisation of
the potencies of the chemicals in the mixture. The Panel further recommended that tiered approach
for both toxicological evaluation and intake estimation be developed in order to make the most
efﬁcient use of the available resources. In this approach, all identiﬁable assumptions and uncertainties
should be evaluated qualitatively and those, which are potentially critical to the outcome of the
assessment, should be examined quantitatively (either by sensitivity analysis or probabilistic
modelling).
In a second Scientiﬁc Opinion adopted in 2009 (EFSA PPR Panel, 2009a,b), the Panel tested a
tiered approach in a case study dedicated to triazole pesticides, using progressive steps of reﬁnement
in the hazard characterisation of mixtures and in the exposure assessment. Based on this exercise, the
panel recommended to establish cumulative assessment groups of pesticides as reﬁned as the data
allow and to restrict the exposure assessment to one deterministic and one probabilistic tiers.
In June 2013, the Scientiﬁc Opinion on the identiﬁcation of pesticides to be included in cumulative
assessment groups on the basis of their toxicological proﬁle (EFSA PPR Panel, 2013a,b,c) was adopted
by the Panel. This opinion has developed a generic methodology to establish CAGs of pesticides. This
methodology comprises four main steps as follows:
• Identiﬁcation of speciﬁc effects (based on their adversity, human relevance, speciﬁcity in the
nature and site of occurrence. . .);
• Characterisation of the identiﬁed speciﬁc effects;
• Collection of appropriate data;
• Grouping of pesticides in a cumulative assessment group related to the speciﬁc effects.
In this opinion, the proposed methodology was illustrated for the effects of pesticides on the
nervous system and on the thyroid function. It must be noted that, in this methodology, the driving
principle to establish cumulative assessment groups is not the observation of a common mode or
mechanism of action, but the common capacity of active substances to produce a certain
phenomenological effect. This approach was followed due to a lack of data on the mode or mechanism
of action; therefore further reﬁnement of the CAGs could not be carried out.
In order to consolidate this strategy, the Panel considered the relevance of dissimilar mode of
action for cumulative risk assessment. In a Scientiﬁc Opinion (EFSA PPR Panel, 2013a,b,c), the
Panel reviewed the scientiﬁc data and evidence which emerged since the ﬁrst opinion in 2008 and
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concluded that the empirical evidence available now suggest that the distinctions between similar and
dissimilar modes of action are fraught with great conceptual and practical difﬁculties and are of limited
practical relevance in cumulative risk assessment. The PPR Panel therefore conﬁrmed the
recommendation to group pesticides producing common adverse outcomes and further recommended
to use the methods based on the concept of dose addition as a pragmatic and conservative default
approach for the purpose of assessing cumulative risks.
Conducting cumulative exposure assessment to pesticides belonging to the same cumulative
assessment group also requires speciﬁc techniques. Probabilistic modelling is essential in this context
because it informs on the distribution of cumulative exposure between all the individuals in a
population following their respective consumption proﬁles. Furthermore, only probabilistic modelling
allows quantifying the frequency of peaks of acute exposure resulting from the simultaneous exposure
to residues of different pesticides present in different commodities and consumed by chance during
one day or eating event.
For this reason, the Panel adopted in 2012 a Guidance on the Use of Probabilistic Methodology for
Modelling Dietary Exposure to Pesticide Residues (EFSA PPR Panel, 2012). This guidance proposes a
strategy for producing basic and reﬁned modelling of probabilistic exposure assessments under
different regulatory scenarios (MRL setting/authorisation and actual exposure) and evaluating the
sources of uncertainties through sensitivity analyses.
In 2014, EFSA adopted an implementation plan for the cumulative risk assessment of pesticides
which will deliver in 2018 the ﬁrst cumulative risk assessments at European level resulting from
pesticides residues in food. These assessments will concern their effects on the nervous system and
the thyroid.
Based on the assumption that adequate hazard data to determine human health-based reference
values that also cover infants and young children must be available for approval of each active
substance, consequently the data and the derived health-based reference values should also be
considered adequate in regard to cumulative risk. Also, the methodology developed for addressing
cumulative risk assessment as such is considered to be applicable for infants and young children as
well. Thus, the grouping methodology based on phenomenological effects as a ﬁrst tier and likewise
the exposure assessment applying probabilistic approaches would be similar.
In conclusion, the already established methodology to address cumulative exposure is also
applicable for infants and young children.
7. Appropriateness of the residue deﬁnitions established under
Regulation (EC) No 396/2005 for foods for infants and young
children (ToR4)
In the EU, the maximum permitted pesticide residue levels in food of plant and animal origin are
set in the Annexes II to V of Regulation (EC) No 396/2005. They are speciﬁc for every pesticide–
commodity combination and are based on the expected residue levels of one or more indicator
compounds, which are included in the particular residue deﬁnition for monitoring. The appropriate
indicator (or set of such marker compounds) is identiﬁed in nature of residue studies and ideally the
transformation of residues under industrial and household-processing conditions to encompass the
entire chain between harvested commodity and marketed end product. MRLs are set before
authorisation at the lowest achievable level consistent with good agricultural practice for each pesticide
with a view to protecting vulnerable groups such as infants, children and the unborn. If no residues
are expected for a pesticide–commodity combination, the MRL is set at the respective analytical limit of
quantiﬁcation.
While residue deﬁnitions for monitoring shall be appropriate for an adequate surveillance of
pesticide applications, they are also intended to allow an indicative, post-authorisation dietary risk
assessment in the framework of Art.32 of Regulation (EC) No 396/2005. However, such an assessment
only allows a more profound conclusion on the dietary risks, if the monitoring residue deﬁnition is
identical to the corresponding residue deﬁnition for risk assessment or, as approximation, if it is
convertible by appropriate factors to the toxicological relevant residue comprising additional
compounds. Apart from these restrictions, such dietary risk assessments rely on information from the
most recent of repetitive active substance assessments, ensuring qualitative and quantitative state-of-
the-art evaluation of pesticide residues as well as of their toxicological proﬁle.
The production of food for infants and young children is governed by speciﬁc requirements as
regards pesticide residues. According to Commission Directives 2006/125/EC and 2006/141/EC, infant
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food shall not contain residues of individual pesticides at levels exceeding 0.01 mg/kg in the ready to use
product or after reconstitution according to the instructions of the manufacturer. MRLs below this
standard level of analytical detection were set for few active substances, which were identiﬁed based on
the toxicological characterisation of that time (ADI < 0.0005 mg/kg bw per day). No considerations were
made on the appropriateness of residue deﬁnitions to cover the nature of residues in the (processed)
product in terms of the residue in the starting material for processing as well as the potential change in
the nature and level of residue during processing. In addition, no update of the legislation for infants and
young children was done since then to account for changes in the agricultural practices, new active
substances, toxicological characterisations of pesticides or analytical developments.
Maximum residue levels refer to different positions in the production chain for infant food
(processed commodities) and for conventional food (raw commodities). In both cases, the underlying
residue deﬁnitions for monitoring should equally allow the surveillance of residue levels post-harvest
and post-processing and should also enable an indicative risk assessment post-MRL setting for all
consumer groups including infants (supported by consumption data and suitable reference values).
Since the scope of the maximum residue levels in food for infants and young children is not different
to those for the general population regulated under Regulation (EU) No 396/2005 (which explicitly
includes vulnerable consumer groups such as children), since adequate food consumption data are
available, and since the tools and methods to assess the dietary risks pre- and post-authorisation are
identical, no difference between legislations is justiﬁed, unless a particular higher or lower protection
goal is expressed by COM for any one consumer group.
The appropriateness of existing residue deﬁnitions established under Regulation (EU) No 396/2005 for
infant food as regulated under Commission Directives 2006/125/EC and 2006/141/EC depends on
whether potential changes in the nature of residue by food-processing operations is covered in the actual
expression of the residue deﬁnition. While, theoretically, the nature of residues in processed commodities
is included in the considerations of setting the residue deﬁnition for monitoring, its practical
implementation has not yet been proven. In order to quantitatively assess the appropriateness of existing
residue deﬁnitions for monitoring according to Regulation (EC) No 396/2005 to processed commodities
including food for infants and young children, the residue deﬁnitions are scrutinised in a tiered approach.
The potential issue of only limited coverage of processing residues by the monitoring residue
deﬁnition is assessed by analysing the impact of relevant processing operations on the marker residue
compounds. Regulatory standard hydrolysis studies for approved active substances indicate how much
of the residue in processed products is covered by the existing residue deﬁnition.
At tier 1, which is included in this opinion, the appropriateness of the currently established single-
compound residue deﬁnitions (SCRD) for processed food is addressed. The aim is to quantify the
degradation potential of the residue of concern under conditions representing processes such as
pasteurisation, cooking of vegetables and cereals, fruit and vegetable preservation, or fruit juice
production, which are relevant processes in the preparation of infant food. This screening assessment
identiﬁes the potential for degradation of residues under harsh, artiﬁcial conditions. A tier 1
assessment is not sufﬁcient to propose any changes in the residue deﬁnitions, since neither the
appropriateness (in terms of analytical approach) nor the amount of particular alternative marker
compounds is investigated under this tier. In view of the MRLs being set at the LOQ, the requirement
for a change of the residue deﬁnitions would have been triggered by higher amounts of a particular
degradate in the processed product compared to parent, and thus, a higher probability of
unintentional misuse of a pesticide being discovered. The sine qua non for further assessment is
therefore degradation of parent in hydrolysis studies of at least 50%.
It is emphasised that the regulatory task of how to combine residue deﬁnitions for raw (Regulation
(EU) No 396/2005) and processed commodities (Directives 2006/125/EC and 2006/141/EC) is a
management issue. The quantitative results might trigger the need to further assess degradation
under realistic processing conditions.
A tier 2 assessment of degradation under realistic conditions, which might be conducted in a follow-up
mandate, should comprise:
i) Substances having a SCRD and proven degradation potential of at least 50% under artiﬁcial
conditions (identiﬁed in tier 1);
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ii) Substances having multicompound residue deﬁnitions (MCRD) and unclear degradation
potential. The level of coverage of the residue deﬁnition of these compounds needs to be
analysed under reﬁned conditions considering information related to the ﬁeld residue situation
of all compounds in the starting material, appropriate industrial-processing conditions, matrix
effects etcetera;
iii) Substances of high toxicity included in the speciﬁc residue deﬁnitions of Directive 2006/125/EC
and Directive 2006/141/EC considering updated information on toxicity and occurrence.
Tier 1 assessment
This assessment is performed for active substances with SCRDs and aims in estimating how much
of the residue in processed products is actually covered by the existing residue deﬁnition, and in how
many cases, a reﬁned tier 2 assessment is triggered.
The potential for changes in the nature of pesticide residues under food processing is analysed by
mimicking representative chemical hydrolysis conditions. The standard regulatory model study (OECD
TG 507, formerly EU Guidance 7035/VI/95 rev.5) requires a range of hydrolytic conditions in buffered
solutions that is employed to the radiolabelled residue in order to simulate normal processing
practices, i.e. pasteurisation (90°C, 20 min, pH 4), baking, brewing, boiling (100°C, 60 min, pH 5), and
sterilisation (120°C, 20 min, pH 6).
For the compilation of active substances in the test data set, compounds need to fulﬁl all of the
following criteria:
1) Active substance is approved under Regulation (EU) No 1107/2009 (n = 494)26
2) Active substance has a single compound residue deﬁnition for products of plant and animal
origin (n = 233)
3) Active substance does not fall under the following exclusion criteria:
a) Multicompound residue deﬁnition for plant and/or animal (n = 73)
b) Inorganic compound OR no residue deﬁnition OR default MRL OR compound included in
Annex IV of Reg. (EU) 396/2005 (n = 189)
Among the approved active substances, 233 active substances have a single compound residue
deﬁnition and do not fall in an exclusion category. Of this group, 111 active substances are covered by
studies on the nature of processing. The remaining 122 compounds are approved with no processing
information required, e.g. due to a no-residue situation, low water solubility or alternative information
showing residue stability on hydrolysis.
The stability of pesticide active substances under industrial- and household-processing conditions is
shown in Figure 1 for the set of 111 compounds, which are covered by hydrolysis data provided in
Appendix D. A recovery of less than 50% of parent is considered as triggering further analysis under
tier 2. On conditions simulating pasteurisation, 4% of active substances considered show recoveries of
parent < 50%. Harsher conditions representative for baking/boiling and for sterilisation show instability
in 12% and 21% of cases, respectively.
26 As of 8 November 2017.
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Based on the analysis of the hydrolysis potential of pesticides with a single-compound residue
deﬁnition, there is doubt on the general appropriateness of existing residue deﬁnitions for monitoring
to cover processed food, both intended for infants and children as well as conventional food.
The assessment is connected with some inherent limitations:
• Real industrial-processing conditions may vary to those applied in the model studies of tier 1;
e.g. conditions of temperature and time that might be found in the preparation of meat and
ﬁsh are not represented by the standard study design.
• No consideration is made on the effective ﬁeld residue situation in treated crops as source of
exposure to infants and young children.
• No consideration is made on matrix effects during processing. For instance, residues bound to
the sample matrix may be more stable to hydrolysis.
• No consideration is made on toxicological properties of the active substances as well as of
undetected hydrolysis products.
• Limited consideration is made on analytical methods for monitoring, which may be capable of
detecting hydrolysis products.
• No consideration is made on MCRD. Conclusions of SCRD should not be generalised to MCRD,
as certain molecule instability, indicated by the breakdown of the parent structure in plants and
animals, is already proven.
• Uncertainties remain as regards deviations from standard study design and reporting of the data:
 In few cases, untypical study designs were chosen. Such studies are compared to
industrial conditions and assessed for exclusion or inclusion to the test data set, taking
into account the indicative character of the assessment.
 Some studies report only percent of parent recovery of the total applied radioactivity in
the tests (losses are considered as potential degradation), others report percent of
chromatogram (losses are considered irrelevant for closed vessels). The numbers were
taken from the report, i.e. both reporting types are considered in parallel; a typical
mass balance of 100  10% is considered acceptable.
 Results of duplicate sample analyses were averaged Results of two labels were reported separately and the worst case taken.
It is recommended to perform a detailed tier 2 analysis considering all-embracing information for
pesticide active substances, including the ﬁeld-residue situation of relevant compounds in the starting
material as well as realistic industrial-processing conditions.
Figure 1: Degradation of pesticide active substances with single-compound residue deﬁnitions under
simulated hydrolysis conditions representative of industrial and household processing
(n = 111)
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8. Summary of uncertainty considerations
The procedure for uncertainty analysis will follow the pattern laid down in the EFSA opinion related
to uncertainties in dietary exposure assessment (EFSA Scientiﬁc Committee, 2007) using a qualitative
tier 1 approach. Before entering the analysis process, it is helpful to summarise the general concerns
about health risk assessment resulting from early life exposures and brieﬂy to describe current views
relevant to this Opinion.
Understanding of human physiological and developmental differences in infants and young children
from adults as summarised here supports the view that sensitivity to chemical exposure in infants
below the age of 4 months is in some cases greater than at other life stages. For risk assessment of
infants older than 4 months, there is still uncertainty in extrapolating from adult information. Any
differential life-stage sensitivity can reﬂect the TK of a xenobiotic exposure and/or the toxicodynamic
(TD) response. Traditional use of UFs designed to protect against short comings in the inter- and
intraspecies variation during the conventional toxicological risk assessment studies are based on
factors of 10. These have been subdivided. For intraspecies variation, allowances of 3.2-fold for TK
and for TD are made. For interspecies differences fourfold for TK and 2.5-fold for TD are the defaults.
These assumptions about the extent of uncertainty have been shown to be broadly adequate for most
cases where detailed knowledge of particular chemicals is available. Such data generally show the
application of default uncertainty factors to allow sufﬁciently protective conclusions. The purpose in
splitting these UFs into subcomponents is to allow chemical-speciﬁc quantitative toxicity information
that affects either TK or TD to be introduced in the appropriate setting. Therefore, replacing
assumption with evidence as it becomes available for the assessment of a speciﬁc chemical’s toxicity
will make the assessment more accurate and reliable. Although overall there is similarity between
laboratory species used for developmental toxicity testing and human, the greatest uncertainty in
interspecies extrapolation arises from differences in timing of relatively similar events that may be
targets for toxicity at sensitive stages of development.
Concerning the biological development and the inﬂuence on TK and TD the guidance on the risk
assessment of substances present in food intended for infants below 16 weeks of age (EFSA Scientiﬁc
Committee, 2017) has extensively described the differences between infants and adults. Concerning
the TK an extensive body of evidence exists which allows to understand and to take into consideration
the differences in a quantitative way. In addition, further work carried out for this opinion elucidated
the situation for infants above 16 weeks. However, the approach which can be taken is based on a
knowledge base of substances not identical with the pesticide under evaluation and brings with it an
uncertainty which cannot be quantiﬁed but can be towards an estimate too high and an estimate too
low. Concerning both the TK and TD in the human species, the Scientiﬁc Committee was of the
opinion, despite knowledge gaps, that the existing testing paradigms in animals would address the
differences appropriately. For pesticide substances, the regulatory requirements are such that the most
critical function in the infant age is addressed with the two generation reproduction toxicity test and,
as recommended in the guidance on the risk assessment of substances present in food intended for
infants below 16 weeks of age (EFSA Scientiﬁc Committee, 2017), the EOGRTS with DNT and DIT
cohorts. However, the use of testing paradigms is based on our current level of knowledge which
means that with changes in the knowledge gaps might be detected. The uncertainty in this respect
cannot be estimated neither qualitatively nor quantitatively.
In producing the opinion, several steps have been performed which may contribute to the
uncertainty surrounding the opinion. Whereas it might be that the restrictions set to ﬁnd and select
relevant publications concerning the biological part of the opinion could result in failure to detect
information, this possibility is judged to be minor and the uncertainty derived from this source is likely
to be extremely low.
For both chronic and acute exposure, there is uncertainty arising from the limited sources of
contemporary food consumption data in all EU Member States.
The regulatory data on RPCs were drawn from premarketing studies of ﬁeld trials leading to STMR,
HR and MRLs were determined using the WHO standard procedures. As the estimates are based on
usage designed to elicit the highest possible residue levels, this procedure causes a consistent bias
towards overestimation of general residue levels. Based on the post-marketing scenario, it was
estimated that premarketing data may overestimate actual exposure by a factor of 2–100 depending
on the active substance. The procedures used to summarise monitoring data favour a bias towards
overestimation of chronic exposure. This bias may be high. For the acute exposure assessments, there
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are uncertainties owing to imprecision of the input data that favour a high estimate. The overestimate
of residue levels is greatest when unit variability factors (VFs) of ﬁve- to sevenfold are applied to
account for variability in residue levels among individual units.
In addition, losses of residues during household or industrial preparation were not considered in the
current assessment which is expected to overestimate even further the exposure estimates.
The conversion of EFSA’s Comprehensive Database into consumption data for raw primary
commodities is still under validation and exposure calculations might still be reﬁned by means of
processing factors.
In the end, limitations for the tier 1 assessment on the appropriateness of residue deﬁnitions
established under Regulation (EC) 396/2005 for foods for infants and young children are listed in
chapter 7. Therefore, a more complete (tier 2) analysis is recommended. From the ﬁrst assessment,
sources of inaccuracy are founded by potential changes of the molecular structure by processing
operations, which may not be covered by the residue deﬁnitions under Regulation (EU) 396/2005. The
other inaccuracy is based on the often divergent residue deﬁnitions of monitoring and risk assessment,
of which the latter may include additional metabolites (see chapter 5.2).
9. Conclusions
Based on the assessment reported in the previous chapters, the following conclusions are provided
by the EFSA PPR Panel:
ToR 1 – The assessment of the appropriateness of the toxicological reference values for pesticides
for infants and young children and of the approach to base the MRLs for pesticides for food for infants
and young children on the ADI values (in this context, the assessment of the short-term dietary risk
should also be considered):
• The established approach for setting ADI and ARfD is appropriate for infants above 16 weeks
of age and young children. For infants below the age of 16 weeks, the established approach
may not be appropriate and the application of the EFSA guidance on risk assessment of
substances in food for infants (EFSA Scientiﬁc Committee, 2017) is recommended.
• It is concluded that potential residues at the default MRL of 0.01 mg/kg for food intended for
infants and young children are not likely to result in an unacceptable exposure to infants below
16 weeks of age for all active substances to which a HBGV of 0.0026 mg/kg bw per day or
higher applies. Lower MRLs, however, are recommended for active substances with HBGV
below 0.0026 mg/kg bw per day, taking into account the guidance on risk assessment of
substances in foods for infants (EFSA Scientiﬁc Committee, 2017). For this approach, it is
recommended to apply the monitoring residue deﬁnitions as harmonised with Regulation (EU)
396/2005 for both monitoring and indicative risk assessment. For active substances with
HBGVs equal or above 0.0026 mg/kg bw per day, conﬁrmation of the acceptability of potential
exposure levels at the default MRL of 0.01 mg/kg should be provided in a detailed assessment.
The assessment should make use of compound-speciﬁc information on the expected nature
and magnitude of residues in processed food for infants and young children as well as on
toxicological properties of the residue of concern.
ToR 2 – The assessment of the contribution of other foods consumed by infants and young children
that are not covered by Regulation (EU) No 609/2013:
• The contribution to the total dietary exposure to pesticides residues of conventional food is
much higher than of foods intended for infants and young children. Contribution of these food
items are generally expected to be less than 5% of the total chronic exposure. For cereal-
based foods and infant formulae, these contributions may go up to around 50% in certain
surveys, in particular for infants between 3 and 6 months of age, but these high contributions
usually refer to surveys with a low total exposure.
• Because of the increased intake of conventional food by young children, these have the
highest exposure to pesticide residues in the investigated populations on a mg/kg bw basis,
whereas infants 3–6 months of age generally have lower exposure.
• Exposure assessments using data for individual daily consumption from EFSA Comprehensive
Database indicate that acute exposure estimates are higher under the chosen boundary
conditions compared to PRIMo v2 calculations. Mean chronic exposure estimates are in the
same range for both models.
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ToR 3 – The impact of a cumulative exposure to pesticides which share a common toxicological
effect:
• The impact of cumulative exposure to pesticide residues on infants and young children is not
different from the general population and the cumulative risk assessment methodology of EFSA
is also applicable to these age groups.
ToR 4 – The appropriateness of residue deﬁnitions established under Regulation (EU) No 396/2005
for foods for infants and young children:
• Differences in the residue deﬁnitions for monitoring between Regulation No (EC) 396/2005 and
for MRLs in food for infants and young children are not considered justiﬁed.
• The appropriateness of the existing residue deﬁnitions under Regulation No (EC) 396/2005 for
foods for infants and young children depends on whether potential changes in the nature of
residue by food-processing operations is covered in the actual expression of the residue
deﬁnition. Based on a tier 1 analysis of the hydrolysis potential of pesticides simulating
processing, the general appropriateness of existing residue deﬁnitions for monitoring to cover
processed food, both intended for infants and young children as well as conventional food is
questionable.
10. Recommendations
Based on the assessment reported in the previous chapters, the following recommendations are
provided by the EFSA PPR Panel:
ToR 1 – The assessment of the appropriateness of the toxicological reference values for pesticides
for infants and young children and of the approach to base the MRLs for pesticides for foods for
infants and young children on the ADI values (in this context, the assessment of the short-term dietary
risk should also be considered):
Overall, it should be recommended in the future to:
• Screen all pesticides for DNT properties in DNT in vitro testing battery (OECD TG 426) to be
developed and triggers for further regulatory studies should be reconsidered;
• Review and improve the DNT (OECD TG426) taking into account considerations discussed in
the approach proposed by Vorhees et al. (2018);
• If a reproductive study is to be performed, it should be the EOGRTS (OECD TG443) with DIT
and DNT cohort.
• For pesticides with allocated HBGVs below 0.0026 mg/kg bw per day, the default MRL of
0.01 mg/kg for foods intended for infants and young children may not be sufﬁciently
protective and therefore lowering could be considered. Since the consumer safety of the
trigger of 0.0026 mg/kg bw per day is connected with uncertainties as regards the pesticide-
speciﬁc degradation under processing conditions, the appropriateness of HBGV to infants and
the relevance of metabolites and degradates, it is recommended to perform a dietary risk
assessment for potential residues of pesticide active substances in food for infants and young
children during a regulated procedure. Moreover, for the risk assessment of potential residues
of pesticide active substances, it is recommended to apply the EFSA PPR guidance on the
establishment of the residue deﬁnition for dietary risk (EFSA PPR Panel, 2016).
ToR 2 – The assessment of the contribution of other foods consumed by infants and young children
that are not covered by Regulation (EU) No 609/2013:
• Clariﬁcation should be provided on the applicability of residue deﬁnitions for monitoring in case
of composite baby food products containing ingredients of animal and plant origin.
• Obtain a contemporary and robust database on food consumption patterns in Europe, and to
improve the overall consumption data quality, the available database should be updated and
expanded to include consumption habits in further countries, in particular for the age classes
addressed under the current mandate. This activity is currently ongoing in the framework of
EFSA’s EU Menu project.27
• Further validation and ﬁnalisation of the RPC model that is used for converting food
consumption data in corresponding amounts of RPC.
27 https://www.efsa.europa.eu/en/data/food-consumption-data
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• EFSA to deﬁne in consultation with risk managers a strategy for the possible implementation of
the newly proposed methodologies in a regulated procedure. Implementation of the proposed
changes may also be considered in a step-wise approach.
ToR 3 – The impact of a cumulative exposure to pesticides which share a common toxicological effect:
• As the cumulative risk assessment methodology currently under development in EFSA is also
applicable to these infants and young children, no speciﬁc recommendations were identiﬁed.
However, since as discussed in this opinion, there are certain effects which are regarded as
critical for infants and young children for which, for example, an acute exposure might have
permanent detrimental effects, this would suggest that cumulative risk assessment
encompassing these effects could be prioritised.
ToR 4 – The appropriateness of residue deﬁnitions established under Regulation (EU) No 396/2005
for foods for infants and young children:
• It is recommended to perform detailed tier 2 analyses on the appropriateness of residue
deﬁnitions for monitoring to cover, besides raw commodities, also processed foods. The
assessment should consider all-embracing information for pesticide active substances and their
relevant metabolites in food intended for infants and young children, taking into account
realistic processing conditions.
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Appendix A – Case studies
A.1. Introduction
In this scientiﬁc opinion, new methodologies are proposed for the assessment of pesticide residues
in foods for infants and young children, in particular (1) for assessing the appropriateness of
toxicological reference values and (2) for calculating dietary exposure in this population group. In
order to test the proposed methodologies, the PPR Panel decided to carry out case studies for ﬁve
active substances, which were selected according to the following criteria:
• all substances should be approved under Regulation (EC) 1107/2009 at the time of publication;
• the MRL review under Article 12 of Regulation (EC) No 396/2005 should be ﬁnalised for all
active substances (in order to ensure availability to EFSA of all premarketing data);
• at least 100 MRLs should have been assessed/proposed for each active substance under Article
12 of Regulation (EC) No 396/2005 (hereby ensuring a wide coverage of foods contributing to
the diets under assessment).
• for each active substance more than 50,000 food samples (including the four main categories
of foods for infants and young children) should be analysed in the latest monitoring program
of 2015;
• substances should be quantiﬁed in more than 1% of the above-mentioned samples (to reduce
as much as possible the uncertainties around left-censored data).
Based on these criteria, eight potential substances were initially presented to the Working Group,
where it was decided to exclude substances producing common metabolites with other compounds
(e.g. tebuconazole/triazoles metabolites, carbendazim) on the grounds that post-marketing data would
require additional assumptions and thereby increasing the uncertainties. Substances under peer review
(e.g. spinosad) at the time of the selection (September 2017) were also excluded. Hence, the
following ﬁve active substances were selected for assessment: azoxystrobin, deltamethrin, ﬂudioxonil,
pyraclostrobin and thiacloprid.
This appendix summarizes the outcome of the case studies where for each active substance,
scenario and age class, the minimum, median and maximum exposure estimates among dietary
surveys are provided. These estimates refer not only to the mean exposure but also to the higher
exposure levels within those surveys. These higher percentile exposures represent consumers that
within a given country and age class are subject to higher exposure compared to the majority of
consumers within the same population (e.g. due to their personal habits and preferences). For
example, looking at Table A.1, it can be seen that among the six surveys available for the infants
between 6 and 12 months of age, mean chronic exposure within a survey may range from 7.9% to
16.2% of the acceptable daily intake (ADI). Considering an exposure level at the 95th percentile for
each survey, the chronic exposure among surveys from the same age class represents between 22.2%
and 45.2% of the ADI. At this exposure level, it can also be seen that only ﬁve dietary surveys are
considered because one dietary survey did not have sufﬁcient subjects in order derive a reliable 95th
percentile. This interpretation can be applied to all tables reporting total chronic and acute exposure.
Detailed results of the exposure calculations for each dietary survey can also be retrieved from
Annex A. This annex also provides an overview of the input data, which were selected according to
the methodologies described in Section 2 of the scientiﬁc opinion.
It should also be noted that the ﬁve case studies selected by the Working Group are primarily
intended for testing of the new methodologies proposed in this scientiﬁc opinion. They are not
intended to support risk managers in taking any substance-speciﬁc measures because these
calculations are still subject to uncertainties that may be further improved in the future:
• At the time of performing the exposure calculations, the conversion of food consumption data
to Raw Primary Commodities (RPC) was still under ﬁnalisation, and inaccuracies in the RPC
consumption data used for exposure assessment cannot be excluded. Previous experience has
shown that such inaccuracies tend to generate extreme consumption values, which is mainly
expected to impact on high percentile exposures. Mean exposure estimates were shown to be
less sensitive for such inaccuracies.
• Except for the effect of peeling observed for some active substances, losses of residues during
household or industrial preparation were not considered in the current assessment, mainly due
to time constraints and the current lack of a database on processing factors in EFSA. However,
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activities on the collection of processing factors are currently ongoing in EFSA and
incorporation of such processing factors in the exposure assessments may signiﬁcantly reduce
some exposure estimates.
Meanwhile, the Working Group is conﬁdent that these calculations are robust enough to inform risk
managers on the impact of the newly proposed methodologies.
For the assessment of the appropriateness of the toxicological reference values for selected
substances, the Working Group evaluated summary information on the toxicity endpoints available in
the relevant assessment documents (EFSA conclusions, EFSA scientiﬁc opinions and European
Commission review reports). The Working Group also took into consideration extracts of the two-
generation reproductive toxicity studies of the ﬁve active substances as special attention may be
needed for young infants.
A.2. Azoxystrobin
A.2.1. Appropriateness of the toxicological reference values
In a dietary two-generation reproductive toxicity study in rats, minor reductions in pup and parental
body weight gain were observed at 170 mg azoxystrobin/kg bw per day (highest dose tested). In
addition, an increase in liver weight was observed in the parental females and pups at this dose; no
histopathological changes were observed in the liver. No effects on reproduction were observed. The no
observed adverse effect level (NOAEL)for reproductive effects was 170 mg azoxystrobin/kg bw per day.
The NOAEL for maternal and developmental effects identiﬁed was 32 mg azoxystrobin/kg bw per day.
The ADI was based on the 2-year rat study and it was set at 0.2 mg azoxystrobin/kg bw per day,
applying an assessment factor of 100. No acute reference dose (ARfD) is allocated (not necessary)
(EFSA, 2010).
The ADI (0.2 mg azoxystrobin/kg bw per day) was based on a NOAEL (using an uncertainty factor, UF
of 100) which was slightly lower than the 32 mg azoxystrobin/kg bw per day the NOAEL for
developmental effects in the two-generation reproductive toxicity study, which was based on minor
changes in pup weight, increased liver weight (in the absence of histopathological ﬁndings). Therefore, an
additional factor for infants above 16 weeks and children up to 3 year is considered not to be applicable.
A.2.2. Exposure of infants below 16 weeks of age
Assuming a default MRL of 0.01 mg/kg (SCF, 1997) and an intake of infant formulae of 260 mL/kg
bw at the highest, this will result in a exposure of approximately 0.0026 mg/kg bw per day. This
exposure is below the ADI of 0.2 mg azoxystrobin/kg bw per day and the default MRL of 0.01 mg/kg
is considered sufﬁciently protective for azoxystrobin.
A.2.3. Exposure of infants above 16 weeks of age and toddlers
A.2.3.1. Chronic exposure assessment
A.2.3.1.1. Premarketing scenario
Based on the premarketing data, chronic exposure to azoxystrobin is expected to be the highest for
toddlers, with mean estimates ranging from 15% to 57% of the ADI (see Table A.1). Depending on
the selected percentiles of exposure, highly exposed toddlers may reach chronic exposures up to 74%
and 97% of the ADI (95th and 97.5th percentiles, respectively). When calculating exposure with
PRIMo v2, mean chronic dietary intakes range from 9% to 17% of the ADI, respectively, for infants
(UK) and toddlers (FR).
The primary commodities contributing the most to the calculated exposure are citrus fruits (oranges,
lemons and mandarins) and potatoes (see Figure A.1). It is noted, however, that a peeling factor for
azoxystrobin in citrus fruits was not reported to EFSA and therefore not included in the exposure
calculation. Hence, the actual exposure through citrus fruits is most likely lower than calculated.
The anticipated chronic exposure for infants is signiﬁcantly lower compared to the exposure calculated
for toddlers and, although the main contributing commodities are the same, the contribution of potatoes
is more important for infants. Another notable contributor identiﬁed for some infant surveys is the group
of ‘Basil and edible ﬂowers’. According to Annex I of Regulation (EC) No 396/2005, this group also covers
mints which may be used as ingredient of certain herbal infusions.
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Assuming a default MRL of 0.01 mg/kg, contribution of speciﬁc foods for infants and young children
to the chronic exposure is expected to be low, except for infants from 3 to 6 months where the
average contribution of infant formulae ranges between 2% and 16% of the total chronic exposure.
A.2.3.1.2. Post-marketing scenario
Based on the upper bound (UB) estimates, the chronic exposure to azoxystrobin was found to be
at least 10–100 times lower compared to the chronic exposure anticipated from the premarketing
scenario. Furthermore, compared to the other active substances assessed, the uncertainty resulting
from left-censored data is high because an approximate 20-fold difference was observed between
lower bound and upper bound estimates (see Table A.2).
Table A.1: Summary statistics of total chronic dietary exposure to azoxystrobin across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
Mean Infants (3–6 months) 3 2.1 3.9 7.2
Infants (6–12 months) 6 7.9 9.7 16.2
Toddlers 10 15.2 21.4 56.5
95th percentile Infants (3–6 months) 2 7.1 11.4 15.7
Infants (6–12 months) 5 22.2 25.8 45.2
Toddlers 7 35.2 54.4 74.2
97.5th percentile Infants (3–6 months) 1 29.3 29.3 29.3
Infants (6–12 months) 4 28.4 31.9 58.9
Toddlers 7 43.9 72.2 97.4
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.1: Mean chronic dietary exposure to azoxystrobin across European dietary surveys,
highlighting the contribution of individual food commodities (premarketing scenario)
Scientiﬁc Opinion on pesticides in foods for infants and young children
www.efsa.europa.eu/efsajournal 43 EFSA Journal 2018;16(6):5286
Oranges, together with a number of other various fruits, were found to be the most important
contributors to the chronic exposure (see Figure A.2). While from the premarketing scenario, potatoes
were also expected to be a signiﬁcant contributor to the exposure, contribution of potatoes to the
actual chronic exposure is low.
As for the premarketing scenario, the exposures were found to be the highest for toddlers and
contribution of speciﬁc foods for infants and young children (including formulae) to the chronic
exposure is low.
Table A.2: Summary statistics of total chronic dietary exposure to azoxystrobin across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 0.00 0.33 0.01 0.40 0.01 0.49
Infants (6–12 months) 6 0.01 0.41 0.02 0.46 0.04 0.59
Toddlers 10 0.02 0.44 0.03 0.53 0.05 0.66
95th percentile Infants (3–6 months) 2 0.02 0.66 0.03 0.80 0.04 0.94
Infants (6–12 months) 5 0.03 0.68 0.04 0.80 0.11 0.89
Toddlers 7 0.05 0.76 0.06 0.80 0.11 0.89
97.5th percentile Infants (3–6 months) 1 0.07 0.98 0.07 0.98 0.07 0.98
Infants (6–12 months) 4 0.03 0.78 0.05 0.89 0.14 0.96
Toddlers 7 0.06 0.82 0.08 0.89 0.13 0.97
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.2: Mean chronic dietary exposure to azoxystrobin across European dietary surveys,
highlighting the contribution of individual food commodities (lower bound post-marketing
scenario)
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A.2.3.2. Acute exposure assessment
Acute exposure calculations were not carried out because an ARfD was not deemed necessary for
this active substance.
A.3. Deltamethrin
A.3.1. Appropriateness of the toxicological reference values
In a dietary two-generation reproductive toxicity, study in rats increased pup mortality and
increased pup weight at a parental toxic dose of 320 mg deltamethrin/kg diet was observed. No
effects on reproductive performance were observed at this dose. The NOAEL for parental and
developmental effects was 80 mg deltamethrin/kg diet, 4.2 mg deltamethrin/kg bw per day.
The ADI of 0.01 mg deltamethrin/kg bw per day was based on the 90-day and 1-year dog studies.
The ARfD was set at 0.01 mg deltamethrin/kg bw per day (European Commission, 2002). UF’s of 100
were used.
In 2009, PPR Panel issued a scientiﬁc opinion on developmental neurotoxicity (EFSA PPR Panel,
2009a,b). No developmental toxicity was observed at the highest dose tested (7 mg deltamethrin/kg
bw per day) in a DNT study complying with OECD guideline 426. The PPR Panel concluded in that
opinion that the ADI derived of the NOAEL of 1 mg deltamethrin/kg bw per day detected in the 90-day
and 1-year dog studies provides adequate protection for neurodevelopmental effects.
The ADI and ARfD (0.01 mg deltamethrin/kg bw per day) were based on a NOAEL of 1 mg/kg bw
per day, which was lower than the NOAEL of 4.2 mg deltamethrin/kg bw per day for developmental
effects in the two-generation toxicity reproductive toxicity study, which was based on increased pup
mortality and increased pup weight at parental toxic dose. Therefore, an additional factor for infants
> 16 weeks and children up to 3 year is considered not to be applicable.
A.3.2. Exposure of infants below 16 weeks of age
Assuming a default MRL of 0.01 mg/kg (SCF, 1997) and an intake of infant formulae of 260 mL/kg
bw at the highest, this will result in a exposure of approximately 0.0026 mg/kg bw per day. This
exposure is below the ADI of 0.01 mg deltamethrin/kg bw per day and the default MRL of 0.01 mg/kg
is considered sufﬁciently protective for deltamethrin.
A.3.3. Exposure of infants above 16 weeks of age and toddlers
A.3.3.1. Chronic exposure assessment
A.3.3.1.1. Premarketing scenario
Based on the premarketing data, chronic exposure to deltamethrin is expected to be the highest for
toddlers, with mean estimates ranging from 66% to 100% of the ADI (see Table A.3). Depending on
the selected percentiles of exposure, highly exposed toddlers may reach chronic exposures up to
150% and 158% of the ADI (95th and 97.5th percentiles, respectively). Although the anticipated
chronic exposure for infants is generally lower compared to the exposure calculated for toddlers, one
survey for infants results in higher exposure estimates representing 175% and 234% of the ADI (95th
and 97.5th percentiles, respectively). With PRIMo v2, mean chronic dietary intakes range from 14% to
44% of the ADI, respectively, for French and UK infants. For toddlers, the highest exposure is 41% of
the ADI (UK toddlers).
The primary commodities contributing the most to the calculated exposure are cereal grains, but
the contribution of the individual grain species (maize, oat, rice, rye and wheat) is very much
depending on the diet (see Figure A.3). Another important contributor throughout all surveys is milk.
These observations are mainly resulting from the fact that deltamethrin is authorised for post-harvest
treatment of cereal grains (which may also be used as a feed item for dairy cattle). However, cereal
grains are mainly consumed in a processed form and it is likely that residues will be lost during such
processing steps. Therefore, inclusion of processing factors in the exposure calculation may
signiﬁcantly reduce the exposure estimates.
Overall, assuming a default MRL of 0.01 mg/kg, contribution of speciﬁc foods for infants and young
children to the chronic exposure was found to be relatively high for processed foods (other than
cereals) and infant formulae where the average contribution in infants may represent up to 7% and
Scientiﬁc Opinion on pesticides in foods for infants and young children
www.efsa.europa.eu/efsajournal 45 EFSA Journal 2018;16(6):5286
54% of the total chronic exposure, respectively. These high contributions, however, usually refer to the
surveys with the lowest total exposures.
A.3.3.1.2. Post-marketing scenario
Based on the UB estimates, the chronic exposure to deltamethrin was found to be only 1–10 times
lower compared to the chronic exposure anticipated from the premarketing scenario. However,
compared to the other active substances assessed, the uncertainty resulting from left-censored data
are high because an approximate 25-fold difference was observed between lower bound and upper
bound estimates (see Table A.4).
Table A.3: Summary statistics of total chronic dietary exposure to deltamethrin across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
Mean Infants (3–6 months) 3 12.4 19.1 47.0
Infants (6–12 months) 6 37.6 49.3 79.1
Toddlers 10 66.0 81.1 100.0
95th percentile Infants (3–6 months) 2 26.8 36.6 46.4
Infants (6–12 months) 5 84.6 111.4 175.3
Toddlers 7 106.2 122.6 149.8
97.5th percentile Infants (3–6 months) 1 61.2 61.2 61.2
Infants (6–12 months) 4 97.2 117.9 234.0
Toddlers 7 122.8 136.8 157.8
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.3: Mean chronic dietary exposure to deltamethrin across European dietary surveys,
highlighting the contribution of individual food commodities (premarketing scenario)
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Overall, the main contributing commodities are cereal grains, which is consistent with those
observed for the premarketing scenario (see Figure A.4). Nevertheless, while from the premarketing
scenario, milk was also expected to be a signiﬁcant contributor to the exposure, its contribution to the
actual chronic exposure is limited.
As for the premarketing scenario, the exposures were found generally to be the highest for toddlers
and contribution of speciﬁc foods for infants and young children (including formulae) to the chronic
exposure is low.
Table A.4: Summary statistics of total chronic dietary exposure to deltamethrin across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 0.04 8.69 0.07 8.85 0.55 11.96
Infants (6–12 months) 6 0.32 9.45 0.51 11.97 0.63 14.56
Toddlers 10 0.62 12.40 0.77 14.65 0.99 19.74
95th percentile Infants (3–6 months) 2 0.20 15.21 0.27 18.93 0.34 22.65
Infants (6–12 months) 5 0.93 18.36 1.51 20.09 1.89 23.70
Toddlers 7 1.12 19.31 1.32 22.42 1.69 30.41
97.5th percentile Infants (3–6 months) 1 0.57 24.22 0.57 24.22 0.57 24.22
Infants (6–12 months) 4 1.09 20.51 1.64 21.77 2.58 26.38
Toddlers 7 1.25 21.34 1.52 24.86 1.93 36.48
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.4: Mean chronic dietary exposure to deltamethrin across European dietary surveys,
highlighting the contribution of individual food commodities (lower bound post-marketing
scenario)
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A.3.3.2. Acute exposure assessment
A.3.3.2.1. Premarketing scenario
Total acute exposure to deltamethrin is generally expected to be the highest in toddlers where,
based on the premarketing data, upper tail exposures may range between 162% and 254% of the
ARfD (depending on the survey and percentile of interest, see Table A.5). Nevertheless, some surveys
for infants leading to even higher exposure were also identiﬁed (up to 408% of the ARfD).
In several surveys, the contribution of background exposure may reach more than 50% of the total
acute exposure, even for the upper tail exposures (see Table A.6). This indicates that, for
deltamethrin, the contribution of background exposures is high compared to other active substances.
As for the chronic exposure calculations, this effect is mainly due to the post-harvest treatment in
cereals, which are widely consumed throughout all surveys and age classes.
Across surveys, the main RPCs driving total acute exposures are maize, apples, oats and pears, also
noting that wheat is an important contributor to the background exposure. Furthermore, when
assessing the acute exposure per RPC (consumers only), exceedances of the ARfD may also be
expected for less frequently consumed RPCs such as rye, millet, buckwheat, aubergines and pumpkins
(see Table A.6). It should be noted however that, for pumpkin, a peeling factor was not available and
therefore not included in the exposure calculations. The high exposure identiﬁed for maize is due to
the consumption of maize oil which requires 25 g of corn to produce only 1 g of oil.
Assuming a default MRL of 0.01 mg/kg, acute exposure through speciﬁc foods for infants and
young children generally ranges from 0.1% to 7.8% of the ARfD, but may reach up to 20.8% of the
ARfD for infant and follow-on formulae (see Annex A – Table 8).
Acute exposure was also calculated with PRIMo v2. For toddlers, highest exposure levels reach 99%
of the ARfD for celery leaves, 98% ARfD for lettuces, 96% ARfD for leeks. For infants (6–12 months), it
was estimated a maximum acute exposure of 98% ARfD for apples and 93% ARfD for maize.
Table A.5: Summary statistics of total acute dietary exposure to deltamethrin across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
Mean Infants (3–6 months) 3 22.8 28.8 73.9
Infants (6–12 months) 6 57.8 83.6 118.3
Toddlers 11 88.4 113.5 147.3
95th percentile Infants (3–6 months) 3 74.6 102.5 281.5
Infants (6–12 months) 5 138.5 180.7 279.8
Toddlers 10 162.0 201.2 247.8
97.5th percentile Infants (3–6 months) 3 104.7 125.6 368.2
Infants (6–12 months) 5 166.1 200.2 407.7
Toddlers 7 175.6 236.0 254.2
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table A.6: Average contribution of the background exposure to the total acute exposure of
deltamethrin across European dietary surveys (premarketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
Full(a) Infants (3–6 months) 3 20.0 22.0 27.8
Infants (6–12 months) 6 36.8 42.2 45.0
Toddlers 11 46.8 52.0 55.8
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A.3.3.2.2. Post-marketing scenario
Total acute exposure to deltamethrin calculated according to the post-marketing scenario (see
Table A.8) is approximately 2–5 times lower than the exposure estimates anticipated by the premarketing
scenario. This ratio is similar to the one observed for the chronic exposure. Regarding the contribution of
the background exposure, the large difference between lower bound (LB) and upper bound (UB)
estimates makes it difﬁcult to assess the contribution of background exposure in the current scenario
(see Table A.9). Nevertheless, compared to the chronic exposure calculations, the impact of this
uncertainty on the total acute exposure estimates is smaller (1.5-fold difference between LB and UB
estimates). Furthermore, background exposure is signiﬁcantly lower than for the premarketing scenario.
The total acute exposure under this scenario is mainly driven by the consumption of bananas,
apples, pumpkins and pears. Also, when assessing the acute exposure for consumers of these RPCs
individually, an exceedance of the ARfD is identiﬁed for pears and pumpkins (see Table A.10). As for
the premarketing scenario, it should be noted that for pumpkin and bananas, a peeling factor was not
available and therefore not included in the exposure calculations. Contribution of cereals, however, is
lower than anticipated from the premarketing scenario.
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
Upper tail(b) Infants (3–6 months) 3 12.2 19.1 31.9
Infants (6–12 months) 5 10.3 32.6 39.8
Toddlers 10 31.5 43.7 58.0
N: number of surveys.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
Table A.7: Summary statistics of the acute dietary exposure to deltamethrin across European
dietary surveys arising from individual raw primary commodities that may lead to an
exceedance of the ARfD (premarketing scenario)
Age class Raw primary commodity N
Acute dietary exposure(a) (% ARfD)
Minimum Median Maximum
Infants (3–6 months) Maize/corn 3 0.8 24.6 339.2
Infants (6–12 months) Apples 5 50.6 81.7 126.8
Pears 5 69.8 117.3 173.5
Maize/corn 5 51.8 109.0 607.7
Common millet/proso millet 2 105.7 198.9 292.0
Oat 5 110.6 164.9 201.1
Rye 5 12.4 63.6 101.1
Toddlers Apples 11 46.7 83.2 100.5
Pears 9 63.5 83.3 108.9
Aubergines/eggplants 4 9.5 55.7 142.2
Pumpkins 1 103.6 103.6 103.6
Buckwheat and other
pseudocereals
4 4.9 43.5 115.1
Maize/corn 11 10.5 74.0 120.4
Oat 6 72.4 150.1 180.4
Rye 9 1.5 52.6 101.7
Wheat 11 50.0 100.3 143.9
N: number of surveys.
(a): The acute dietary exposure refers to the highest percentile that is considered statistically robust for a given dietary survey,
age class and food, considering that a minimum of 12, 30, 61 and 181 observations are, respectively, required to derive
75th, 90th, 95th and 97.5th percentile estimates (EFSA, 2011a). Estimates with less than 12 observations were not included
in this table.
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Acute exposure to through speciﬁc foods for infants and young children ranged from 0.5% to
13.8% of the ARfD and exposures up to 54.6% of the ARfD were noted for infant formulae (see
Annex A – Table 8). These estimates were, however, derived from left-censored monitoring data.
Table A.8: Summary statistics of total acute dietary exposure to deltamethrin across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 13.6 18.9 15.3 19.1 16.3 21.8
Infants (6–12 months) 6 21.7 29.0 25.4 35.3 44.7 53.5
Toddlers 11 23.0 34.5 28.4 41.9 39.2 57.1
95th percentile Infants (3–6 months) 3 29.5 42.9 42.2 52.7 43.7 57.8
Infants (6–12 months) 5 48.8 58.0 52.8 67.0 76.8 91.1
Toddlers 10 46.7 61.2 52.8 72.6 63.9 98.0
97.5th percentile Infants (3–6 months) 3 36.7 50.3 56.9 64.1 61.7 74.0
Infants (6–12 months) 5 53.4 62.2 61.2 75.6 106.9 121.6
Toddlers 7 53.0 68.2 57.5 73.2 69.0 87.8
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table A.9: Average contribution of the background exposure to the total acute exposure of
deltamethrin across European dietary surveys (post-marketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
LB UB LB UB LB UB
Full(a) Infants (3–6 months) 3 0.3 16.9 0.4 25.2 2.3 25.6
Infants (6–12 months) 6 0.9 25.0 2.4 28.9 3.2 36.0
Toddlers 11 2.6 30.6 3.5 37.5 4.4 39.3
Upper tail(b) Infants (3–6 months) 3 0.1 14.2 0.5 21.1 5.9 30.8
Infants (6–12 months) 5 0.6 12.4 1.0 18.2 1.4 22.0
Toddlers 10 1.1 22.2 1.3 27.6 2.2 39.9
LB: lower bound; N: number of surveys; UB: upper bound.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
Table A.10: Summary statistics of the acute dietary exposure to deltamethrin across European
dietary surveys arising from raw primary commodities that may lead to an exceedance
of the ARfD (post-marketing scenario)
Age class Raw primary commodity N
Acute dietary exposure(a) (% ARfD)
Minimum Median Maximum
Infants (6–12 months) Pears 5 43.6 73.3 108.4
Pumpkins 2 137.3 330.7 524.0
Toddlers Pumpkins 1 573.3 573.3 573.3
N: number of surveys.
(a): The acute dietary exposure refers to the highest percentile that is considered statistically robust for a given dietary survey,
age class and food, considering that a minimum of 12, 30, 61 and 181 observations are, respectively, required to derive
75th, 90th, 95th and 97.5th percentile estimates (EFSA, 2011a). Estimates with less than 12 observations were not included
in this table.
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A.4. Fludioxonil
A.4.1. Appropriateness of the toxicological reference values
In a dietary two-generation reproductive toxicity study in rats, decreased pup weight and in the
parental animals decreased body weight and food consumption were observed at 3,000 mg
ﬂudioxonil/kg diet, the highest dose tested. At 300 mg ﬂudioxonil/kg diet, no effects were observed.
No effects on reproductive performance were observed at 3,000 mg ﬂudioxonil (212 mg ﬂudioxonil/kg
bw per day). The NOAEL for parental and developmental effects was 300 mg ﬂudioxonil/kg diet
(21 mg ﬂudioxonil/kg bw per day).
The ADI of 0.37 mg ﬂudioxonil/kg bw per day was based on a 2-year rat study, applying an
assessment factor of 100 (EFSA, 2007a,b). No ARfD was allocated (not necessary).
The ADI (0.37 mg ﬂudioxonil/kg bw per day) was based on a NOAEL which was higher than or
comparable to the NOAEL of 21 mg ﬂudioxonil/kg bw per day for developmental effects in the two-
generation toxicity reproductive toxicity study, which was based on decreased pup weight. The
justiﬁcation for the NOAEL chosen for setting ADI was based on dose spacing in the studies, and in
addition, there were no reproductive effects.
A.4.2. Exposure of infants below 16 weeks of age
Assuming a default MRL of 0.01 mg/kg (SCF, 1997) and an intake of infant formulae of 260 mL/kg
bw at the highest, this will result in a exposure of approximately 0.0026 mg/kg bw per day. This
exposure is below the ADI of 0.37 mg ﬂudioxonil/kg bw per day and the default MRL of 0.01 mg/kg is
considered sufﬁciently protective for ﬂudioxonil.
A.4.3. Exposure of infants above 16 weeks of age and toddlers
A.4.3.1. Chronic exposure assessment
A.4.3.1.1. Premarketing scenario
Based on the premarketing data, chronic exposure to ﬂudioxonil is expected to be the highest for
toddlers, with mean estimates ranging from 8% to 38% of the ADI (see Table A.11). Depending on
the selected percentiles of exposure, highly exposed toddlers may reach chronic exposures up to 50%
and 62% of the ADI (95th and 97.5th percentiles, respectively). When calculating exposure with
PRIMo v2, mean chronic dietary intakes range from 5% to 10% of the ADI, respectively, for UK infants
and French toddlers.
The primary commodities contributing the most to the calculated exposure are citrus fruits
(oranges, lemons and mandarins), apples and potatoes (see Figure A.5). It is noted, however, that a
peeling factor for ﬂudioxonil in citrus fruits was not reported to EFSA and therefore not included in the
exposure calculation. Hence, the actual exposure through citrus fruits is most likely lower than
calculated.
Although the anticipated chronic exposure for infants is signiﬁcantly lower compared to the
exposure calculated for toddlers, the main contributors are the same.
Overall, assuming a default MRL of 0.01 mg/kg, contribution of speciﬁc foods for infants and young
children to the chronic exposure is expected to be low, except for infants from 3 to 6 months where
the average contribution of infant formulae ranges between 2% and 8% of the total chronic exposure.
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A.4.3.1.2. Post-marketing scenario
Based on the UB estimates, the chronic exposure to ﬂudioxonil was found to be at least 10–50
times lower compared to the chronic exposure anticipated from the premarketing scenario. However,
compared to the other active substances assessed, the uncertainty resulting from left-censored data is
low because an approximate sixfold difference was observed between lower bound and upper bound
estimates (see Table A.12).
Overall, fruits (including apples) were found to be the most important contributors to the chronic
exposure and, in a few surveys, sweet potatoes were the major contributor (see Figure A.6). Although
Table A.11: Summary statistics of total chronic dietary exposure to ﬂudioxonil across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
Mean Infants (3–6 months) 3 2.4 3.9 5.3
Infants (6–12 months) 6 5.3 6.8 11.0
Toddlers 10 8.3 15.8 38.0
95th percentile Infants (3–6 months) 2 10.2 14.1 17.9
Infants (6–12 months) 5 13.5 17.6 27.6
Toddlers 7 19.2 39.6 49.9
97.5th percentile Infants (3–6 months) 1 19.9 19.9 19.9
Infants (6–12 months) 4 15.8 19.0 35.5
Toddlers 7 27.6 50.0 62.6
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.5: Mean chronic dietary exposure to ﬂudioxonil across European dietary surveys,
highlighting the contribution of individual food commodities (premarketing scenario)
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from the premarketing scenario, citrus fruits and potatoes were also expected to be signiﬁcant
contributors to the exposure, their contribution to the actual exposure is low.
As for the premarketing scenario, the exposures were found to be the highest for toddlers and
contribution of speciﬁc foods for infants and young children (including formulae) to the chronic
exposure is low.
Table A.12: Summary statistics of total chronic dietary exposure to ﬂudioxonil across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 0.03 0.26 0.04 0.28 0.07 0.38
Infants (6–12 months) 6 0.05 0.38 0.07 0.41 0.09 0.58
Toddlers 10 0.07 0.48 0.10 0.59 0.15 0.69
95th percentile Infants (3–6 months) 2 0.23 0.60 0.29 0.72 0.34 0.84
Infants (6–12 months) 5 0.16 0.69 0.19 0.79 0.35 0.93
Toddlers 7 0.20 0.79 0.25 0.93 0.30 1.01
97.5th percentile Infants (3–6 months) 1 0.27 0.99 0.27 0.99 0.27 0.99
Infants (6–12 months) 4 0.23 0.87 0.31 0.91 0.49 1.02
Toddlers 7 0.26 0.88 0.31 1.02 0.42 1.22
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.6: Mean chronic dietary exposure to ﬂudioxonil across European dietary surveys,
highlighting the contribution of individual food commodities (lower bound post-marketing
scenario)
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A.4.3.2. Acute exposure assessment
Acute exposure calculations were not carried out because an ARfD was not deemed necessary for
this active substance.
A.5. Pyraclostrobin
A.5.1. Appropriateness of the toxicological reference values
In a dietary two-generation reproductive toxicity study in rats, decreased pup weight gain,
decreased thymus and spleen weights at weaning in the presence of parental toxicity were observed
at 300 mg pyraclostrobin/kg diet the highest dose tested. At 75 mg pyraclostrobin/kg diet (8.2 mg
pyraclostrobin/kg bw per day), no effects were observed. No effects on reproductive performance
were observed at 300 mg pyraclostrobin/kg diet (32.6 mg pyraclostrobin/kg bw per day). The NOAEL
for parental and developmental effects was 75 mg pyraclostrobin/kg diet (8.2 mg pyraclostrobin/kg bw
per day). The lowest NOAEL identiﬁed was found in the prenatal developmental toxicity study in
rabbits at 3 mg pyraclostrobin/kg bw per day, and in the same study, the NOAEL for developmental
toxicity was 5 mg pyraclostrobin/kg bw per day in this study.
The ADI and ARfD (0.03 mg pyraclostrobin/kg bw per day) were based on the NOAEL (3 mg
pyraclostrobin/kg bw per day) of a chronic study in rats and maternal toxicity in a prenatal
developmental toxicity study in rabbits (European Coimmission, 2004). The NOAEL for parental and
developmental effects in the two-generation reproductive toxicity study was 75 mg pyraclostrobin/kg
diet (8.2 mg pyraclostrobin/kg bw per day. Therefore, an additional factor for infants > 16 weeks and
children up to 3 years are considered not to be applicable.
A.5.2. Exposure of infants below 16 weeks of age
Assuming a default MRL of 0.01 mg/kg (SCF, 1997) and an intake of infant formulae of 260 mL/kg bw
at the highest, this will result in a exposure of approximately 0.0026 mg/kg bw per day. This exposure is
below the ADI of 0.03 mg pyraclostrobin/kg bw per day and the default MRL of 0.01 mg/kg is
considered sufﬁciently protective for pyraclostrobin.
A.5.3. Exposure of infants above 16 weeks of age and toddlers
A.5.3.1. AChronic exposure assessment
A.5.3.1.1. Premarketing scenario
Based on the premarketing data, chronic exposure to pyraclostrobin is expected to be the highest
for toddlers, with mean estimates ranging from 13% to 20% of the ADI (see Table A.13). Depending
on the selected percentiles of exposure, highly exposed toddlers may reach chronic exposures up to
39% and 47% of the ADI (95th and 97.5th percentiles, respectively). The anticipated chronic exposure
for infants is signiﬁcantly lower compared to the exposure calculated for toddlers. When calculating
exposure with PRIMo v2, mean chronic dietary intakes range from 5.5% to 8% of the ADI,
respectively, for infants and toddlers (FR diets).
The primary commodities contributing the most to the calculated exposure are in this case difﬁcult
to identify because they are very dependent on the dietary survey, but the most frequently reported
commodities include various citrus fruits, pome fruits, berry fruits, milk and sugar beets (see
Figure A.7). The exposure from sugar beets is driven by the consumption of sugar, but the current
assessment does not consider the possible loss of residues during sugar production. Exposure
estimates are therefore likely to be overestimated.
Overall, assuming a default MRL of 0.01 mg/kg, contribution of speciﬁc foods for infants and young
children to the chronic exposure was found to be relatively high for processed foods (other than
cereals) and infant formulae where the average contribution in infants may represent up to 10% and
49% of the total chronic exposure, respectively. These high contributions, however, usually refer to the
surveys with the lowest total exposures.
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A.5.3.1.2. Post-marketing scenario
Based on the UB estimates, the chronic exposure to pyraclostrobin was found to be only 3–6 times
lower compared to the chronic exposure anticipated from the premarketing scenario. However,
compared to the other active substances assessed, the uncertainty resulting from left-censored data is
high because an approximate 20-fold difference was observed between lower bound and upper bound
estimates (see Table A.14).
The most important contributors to the chronic exposure are apples, pears and currants (see
Figure A.8). Although from the premarketing scenario, milk was also expected to be a signiﬁcant
contributor to the exposure, its contribution to the actual exposure is low.
Table A.13: Summary statistics of total chronic dietary exposure to pyraclostrobin across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
Mean Infants (3–6 months) 3 4.6 4.9 8.1
Infants (6–12 months) 6 9.1 10.3 12.7
Toddlers 10 13.1 17.5 20.5
95th percentile Infants (3–6 months) 2 9.7 14.6 19.6
Infants (6–12 months) 5 19.0 22.9 25.8
Toddlers 7 26.7 34.5 39.3
97.5th percentile Infants (3–6 months) 1 21.9 21.9 21.9
Infants (6–12 months) 4 23.2 26.3 29.9
Toddlers 7 32.6 38.6 47.2
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.7: Mean chronic dietary exposure to pyraclostrobin across European dietary surveys,
highlighting the contribution of individual food commodities (premarketing scenario)
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As for the premarketing scenario, the exposures were found to be the highest for toddlers and
contribution of speciﬁc foods for infants and young children (including formulae) to the chronic
exposure is low.
Table A.14: Summary statistics of total chronic dietary exposure to pyraclostrobin across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 0.04 2.33 0.07 2.71 0.10 3.42
Infants (6–12 months) 6 0.09 2.72 0.13 3.18 0.21 3.98
Toddlers 10 0.14 3.20 0.23 3.73 0.32 4.18
95th percentile Infants (3–6 months) 2 0.25 4.49 0.32 5.52 0.38 6.54
Infants (6–12 months) 5 0.30 4.82 0.35 5.43 0.52 5.89
Toddlers 7 0.38 5.16 0.58 5.55 0.75 6.22
97.5th percentile Infants (3–6 months) 1 0.46 6.90 0.46 6.90 0.46 6.90
Infants (6–12 months) 4 0.34 5.25 0.40 6.06 0.65 6.30
Toddlers 7 0.45 5.50 0.75 6.19 0.87 6.80
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.8: Mean chronic dietary exposure to pyraclostrobin across European dietary surveys,
highlighting the contribution of individual food commodities (lower bound post-marketing
scenario)
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A.5.3.2. Acute exposure assessment
A.5.3.2.1. Premarketing scenario
Total acute exposure to pyraclostrobin is expected to be the highest in toddlers where, based on
the premarketing data, upper tail exposures may range between 67 and 109% of the ARfD
(depending on the survey and percentile of interest, see Table A.15). While the contribution of
background exposure is generally 20–40% of the total acute exposure, background exposure only
accounts for 10–35% in the upper tail exposures (see Table A.16). This indicates that high acute
exposures to pyraclostrobin are very much driven by speciﬁc food items.
Across surveys, the main RPCs driving total acute exposures are table grapes, onions, currants and
apricots. Furthermore, when assessing the acute exposure per RPC (consumers only), an exceedance
of the ARfD may also be expected for less frequently consumed RPCs such as apricots and rose hips
(see Table A.17).
Assuming a default MRL of 0.01 mg/kg, acute exposure through speciﬁc foods for infants and
young children generally ranges from 0.1% to 2.6% of the ARfD, but may reach up to 6.9% of the
ARfD for infant and follow-on formulae (see Annex A – Table 8).
Using PRIMo v2, the highest exposure levels are 157% of the ARfD for toddlers (table grapes and
kale) with no other ARfD exceedance. For infants (6–12 months), the highest exposure is 95% of the
ARfD for apples.
Table A.15: Summary statistics of total acute dietary exposure to pyraclostrobin across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
Mean Infants (3–6 months) 3 11.7 12.0 15.1
Infants (6–12 months) 6 23.9 25.5 34.4
Toddlers 11 30.2 36.4 46.6
95th percentile Infants (3–6 months) 3 31.5 41.1 48.5
Infants (6–12 months) 5 52.0 75.3 82.4
Toddlers 10 67.2 79.1 103.4
97.5th percentile Infants (3–6 months) 3 34.0 50.3 59.8
Infants (6–12 months) 5 61.3 84.0 98.0
Toddlers 7 80.4 90.3 108.8
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table A.16: Average contribution of the background exposure to the total acute exposure of
pyraclostrobin across European dietary surveys (premarketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
Full(a) Infants (3–6 months) 3 17.0 25.0 26.8
Infants (6–12 months) 6 28.1 31.5 37.0
Toddlers 11 29.5 36.9 41.2
Upper tail(b) Infants (3–6 months) 3 13.8 13.9 19.2
Infants (6–12 months) 5 16.2 19.3 29.5
Toddlers 10 21.3 25.1 35.3
N: number of surveys.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
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A.5.3.2.2. Post-marketing scenario
Total acute exposure to pyraclostrobin calculated according to the post-marketing scenario (see
Table A.18) is approximately 4–9 times lower than the exposure estimates anticipated by the
premarketing scenario. This ratio is similar to the one observed for the chronic exposure. Regarding the
contribution of the background exposure, the large difference between LB and UB estimates makes it
difﬁcult to assess the contribution of background exposure in the current scenario (see Table A.19).
Nevertheless, compared to the chronic exposure calculations, the impact of this uncertainty on the total
acute exposure estimates is smaller (twofold difference between LB and UB estimates).
The total acute exposure under this scenario is mainly driven by the consumption of pears. When
assessing the acute exposure per RPC (consumers only), the highest exposure was also observed for
pears, up to 18% of the ARfD (see Annex A – Table 8). Other important drivers to the acute exposure
are apples, currants and peaches. Apricots, rose hips and onions, which on the basis of the
premarketing scenario were expected to be important drivers of the acute exposure, resulted in low
exposure under the current scenario because concentrations in the monitoring data were much lower
than those retrieved from the regulatory data, or not available in the case of rose hips.
Acute exposure to through speciﬁc foods for infants and young children (mainly derived from
left-censored monitoring data) were similar to those observed for the premarketing scenario.
Table A.17: Summary statistics of the acute dietary exposure to pyraclostrobin across European
dietary surveys arising from raw primary commodities that may lead to an exceedance
of the ARfD (premarketing scenario)
Age class Raw primary commodity N
Acute dietary exposure(a) (% ARfD)
Minimum Median Maximum
Toddlers Rose hips 3 35.0 51.5 107.4
N: number of surveys.
(a): The acute dietary exposure refers to the highest percentile that is considered statistically robust for a given dietary survey,
age class and food, considering that a minimum of 12, 30, 61 and 181 observations are, respectively, required to derive
75th, 90th, 95th and 97.5th percentile estimates (EFSA, 2011a). Estimates with less than 12 observations were not included
in this table.
Table A.18: Summary statistics of total acute dietary exposure to pyraclostrobin across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 2.3 3.5 2.8 3.6 3.1 4.2
Infants (6–12 months) 6 2.5 4.4 2.7 5.0 3.9 5.9
Toddlers 11 2.3 4.9 2.9 5.6 3.6 7.1
95th percentile Infants (3–6 months) 3 4.8 7.0 5.5 7.6 6.6 7.8
Infants (6–12 months) 5 4.9 8.3 5.6 9.5 6.6 11.1
Toddlers 10 4.8 9.0 5.8 9.9 6.9 11.7
97.5th percentile Infants (3–6 months) 3 5.2 9.0 6.2 9.7 7.0 10.2
Infants (6–12 months) 5 6.4 9.9 6.6 10.9 9.2 13.9
Toddlers 7 6.2 10.2 6.6 10.7 7.7 11.7
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
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A.6. Thiacloprid
A.6.1. Appropriateness of the toxicological reference values
In a dietary two-generation reproductive toxicity study in rats, decreased pup weight (300 and
600 mg thiacloprid/kg diet) and viability (600 mg thiacloprid/kg diet) were observed at maternally
toxic dose levels (300 and 600 mg thiacloprid/kg diet). At these dose levels also, dystocia was
observed in the dams. In the high-dose group (600 mg thiacloprid/kg diet), decreased body weights
were observed in both sexes. In addition, increased macroscopical and histopathological changes were
observed in the liver and thyroid of the parental animals in the 300 and 600 mg thiacloprid/kg diet
groups. The low-dose group 50 mg thiacloprid/kg diet (2.7 mg thiacloprid/kg bw per day) was
identiﬁed as the NOAEL. The lowest relevant NOAEL for developmental toxicity of 2 mg thiacloprid/kg
bw was detected in the prenatal developmental toxicity study in rabbits.
The ADI of 0.01 mg thiacloprid/kg bw per day was based on the 2-year rat study, applying an UF
of 100 (European Commission, 2004a,b). The ARfD was set on 0.03 mg thiacloprid/kg bw per day
based on the acute neurotoxicity study rat using an UF of 100.
The ADI of 0.01 mg thiacloprid/kg bw per day was based on the NOAEL of a chronic 2-year study in
rats of 1 mg thiacloprid/kg bw per day. The ARfD was set on 0.03 mg thiacloprid/kg bw per day based on
the acute neurotoxicity study rat. In the two-generation reproductive toxicity study in rats, a NOAEL of
2.7 mg thiacloprid/kg bw per day for developmental effects identiﬁed. This NOAEL was approximately
three times higher than the NOAEL identiﬁed from the chronic 2-year study in rats. Therefore, an
additional factor for infants > 16 weeks and children up to 3 years is considered not to be applicable.
A.6.2. Exposure of infants below 16 weeks of age
Assuming a default MRL of 0.01 mg/kg (SCF, 1997) and an intake of infant formulae of 260 mL/kg
bw at the highest, this will result in a exposure of approximately 0.0026 mg/kg bw per day. This
exposure is below the ADI of 0.01 mg thiacloprid/kg bw per day and the default MRL of 0.01 mg/kg is
considered sufﬁciently protective for thiacloprid.
A.6.3. Exposure of infants above 16 weeks of age and toddlers
A.6.3.1. Chronic exposure assessment
A.6.3.1.1. Premarketing scenario
Based on the premarketing data, chronic exposure to thiacloprid is expected to be the highest for
toddlers, with mean estimates ranging from 36% to 68% of the ADI (see Table A.20). Depending on
the selected percentiles of exposure, highly exposed toddlers may reach chronic exposures up to 79%
and 90% of the ADI (95th and 97.5th percentiles respectively). The anticipated chronic exposure for
infants is lower compared to the exposure calculated for toddlers. When calculating exposure with
Table A.19: Average contribution of the background exposure to the total acute exposure of
pyraclostrobin across European dietary surveys (post-marketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
LB UB LB UB LB UB
Full(a) Infants (3–6 months) 3 0.8 17.5 1.9 25.7 1.9 29.3
Infants (6–12 months) 6 1.5 39.5 2.8 43.8 3.6 51.7
Toddlers 11 2.9 46.9 5.0 54.3 7.0 60.4
Upper tail(b) Infants (3–6 months) 3 1.3 37.4 1.5 37.5 2.3 45.9
Infants (6–12 months) 5 1.1 29.4 2.0 37.3 2.8 45.9
Toddlers 10 1.8 35.9 3.3 43.3 5.0 48.8
LB: lower bound; N: number of surveys; UB: upper bound.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
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PRIMo v2, mean chronic dietary intakes range from 16% to 23% of the ADI, respectively, for infants
and toddlers (FR diets).
The primary commodities contributing the most to the calculated exposure are milk, apples and
tomatoes (see Figure A.9). Also, olives for oil production are expected to be an important contributor
in certain surveys.
Overall, assuming a default MRL of 0.01 mg/kg, contribution of speciﬁc foods for infants and young
children to the chronic exposure was found to be relatively high for processed foods (other than
cereals) and infant formulae where the average contribution in infants may represent up to 10% and
55% of the total chronic exposure, respectively. These high contributions, however, usually refer to the
surveys with the lowest total exposures.
Table A.20: Summary statistics of total chronic dietary exposure to thiacloprid across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
Mean Infants (3–6 months) 3 12.3 13.0 22.7
Infants (6–12 months) 6 23.6 27.2 53.7
Toddlers 10 36.2 44.1 68.2
95th percentile Infants (3–6 months) 2 23.9 40.3 56.6
Infants (6–12 months) 5 48.3 51.2 78.7
Toddlers 7 60.7 70.4 78.5
97.5th percentile Infants (3–6 months) 1 72.5 72.5 72.5
Infants (6–12 months) 4 53.4 55.6 85.1
Toddlers 7 67.9 80.9 89.9
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Figure A.9: Mean chronic dietary exposure to thiacloprid across European dietary surveys,
highlighting the contribution of individual food commodities (premarketing scenario)
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A.6.3.1.2. Post-marketing scenario
Based on the UB estimates, the chronic exposure to thiacloprid was found to be only 2–5 times
lower compared to the chronic exposure anticipated from the premarketing scenario. However,
compared to the other active substances assessed, the uncertainty resulting from left-censored data is
very high because an approximate 50-fold difference was observed between lower bound and upper
bound estimates (see Table A.21).
The most important contributors to the chronic exposure are apples, pears and currants (see
Figure A.10). Although from the premarketing scenario milk was also expected to be a signiﬁcant
contributor to the exposure, its contribution to the actual exposure is low.
As for the premarketing scenario, the exposures were found to be the highest for toddlers and
contribution of speciﬁc foods for infants and young children (including formulae) to the chronic
exposure is low.
Table A.21: Summary statistics of total chronic dietary exposure to thiacloprid across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total chronic dietary exposure (% ADI)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 0.05 9.18 0.09 11.64 0.14 14.43
Infants (6–12 months) 6 0.14 10.57 0.22 12.47 0.33 16.17
Toddlers 10 0.22 13.97 0.39 14.68 0.54 17.86
95th percentile Infants (3–6 months) 2 0.30 20.29 0.41 24.50 0.51 28.70
Infants (6–12 months) 5 0.43 17.37 0.53 24.23 0.99 25.23
Toddlers 7 0.60 21.81 1.13 23.16 1.46 28.06
97.5th percentile Infants (3–6 months) 1 0.67 31.07 0.67 31.07 0.67 31.07
Infants (6–12 months) 4 0.54 21.96 0.64 26.37 1.14 27.96
Toddlers 7 0.79 24.11 1.53 25.06 2.08 29.37
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
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A.6.3.2. Acute exposure assessment
A.6.3.2.1. Premarketing scenario
Total acute exposure to thiacloprid is expected to be the highest in toddlers where, based on the
premarketing data, upper tail exposures may range between 58% and 133% of the ARfD (depending
on the survey and percentile of interest, see Table A.22). While the contribution of background
exposure generally ranges between 18% and 41% of the total acute exposure, background exposure
only accounts for 8–30% in the upper tail exposures (see Table A.23). This indicates that high acute
exposures to thiacloprid are very much driven by speciﬁc food items.
Across surveys, the main RPCs driving total acute exposures are peaches, raspberries, olives for oil
production and apples. Also when assessing the acute exposure for consumers of these RPCs
individually, an exceedance of the ARfD may be expected, except for apples (see Table A.24).
Assuming a default MRL of 0.01 mg/kg, acute exposure through speciﬁc foods for infants and
young children generally ranges from 0.1% to 2.6% of the ARfD, but may reach up to 6.9% of the
ARfD for infant and follow-on formulae (see Annex A – Table 8).
With PRIMo v2, the highest acute levels are 52% of the ARfD for apples and infants (UK), and 50%
of the ARfD for celery leaves and toddlers (BE).
Figure A.10: Mean chronic dietary exposure to thiacloprid across European dietary surveys,
highlighting the contribution of individual food commodities (lower bound post-
marketing scenario)
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A.6.3.2.2. Post-marketing scenario
Total acute exposure to thiacloprid calculated according to the post-marketing scenario (see
Table A.25) is approximately 2–8 times lower than the exposure estimates anticipated by the
Table A.22: Summary statistics of total acute dietary exposure to thiacloprid across European
dietary surveys (premarketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
Mean Infants (3–6 months) 3 9.9 10.5 15.2
Infants (6–12 months) 6 19.6 25.3 55.7
Toddlers 11 24.4 34.1 65.5
95th percentile Infants (3–6 months) 3 25.6 39.5 61.1
Infants (6–12 months) 5 50.2 66.5 105.9
Toddlers 10 57.7 68.9 132.8
97.5th percentile Infants (3–6 months) 3 30.2 47.9 93.2
Infants (6–12 months) 5 60.6 79.3 120.4
Toddlers 7 68.6 80.5 118.9
N: number of surveys.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table A.23: Average contribution of the background exposure to the total acute exposure of
thiacloprid across European dietary surveys (premarketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
Full(a) Infants (3–6 months) 3 18.1 22.4 27.3
Infants (6–2 months) 6 22.2 34.8 38.4
Toddlers 11 22.1 37.9 41.3
Upper tail(b) Infants (3–6 months) 3 9.7 10.0 27.2
Infants (6–12 months) 5 12.4 14.1 22.2
Toddlers 10 10.6 21.9 29.5
N: number of surveys.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
Table A.24: Summary statistics of the acute dietary exposure to thiacloprid across European dietary
surveys arising from raw primary commodities that may lead to an exceedance of the
ARfD (premarketing scenario)
Age class Raw primary commodity N
Acute dietary exposure(a) (% ARfD)
Minimum Median Maximum
Infants (3–6 months) Peaches 1 107.2 107.2 107.2
Infants (6–12 months) Peaches 5 65.9 94.3 112.6
Toddlers Peaches 7 28.2 85.4 119.4
Raspberries (red and yellow) 7 34.7 45.8 115.2
Olives for oil production 11 3.8 26.8 126.0
N: number of surveys.
(a): The acute dietary exposure refers to the highest percentile that is considered statistically robust for a given dietary survey,
age class and food, considering that a minimum of 12, 30, 61 and 181 observations are respectively required to derive 75th,
90th, 95th and 97.5th percentile estimates (EFSA, 2011a). Estimates with less than 12 observations were not included in
this table.
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premarketing scenario. This ratio is similar to the one observed for the chronic exposure. Regarding
the contribution of the background exposure, the large difference between LB and UB estimates
makes it difﬁcult to assess the contribution of background exposure in the current scenario (see
Table A.26). Nevertheless, compared to the chronic exposure calculations, the impact of this
uncertainty on the total acute exposure estimates is smaller (twofold difference between LB and UB
estimates).
The total acute exposure under this scenario is mainly driven by the consumption of pears and
potatoes. When assessing the acute exposure per RPC (consumers only), the highest exposure were
also observed for pears and potatoes, up to 17% and 11% of the ARfD, respectively (see Annex A –
Table 8). Peaches, raspberries and olives for oil production, which on the basis of the premarketing
scenario were expected to be important drivers of the acute exposure, resulted in low exposure under
the current scenario because concentrations in the monitoring data were much lower than those
retrieved from the regulatory data.
Acute exposure to through speciﬁc foods for infants and young children ranged from 0.1% to 2.5%
of the ARfD and exposures up to 13.8% of the ARfD were noted for infant formulae (see Annex A –
Table 8). These estimates were, however, derived from left-censored monitoring data.
Table A.25: Summary statistics of total acute dietary exposure to thiacloprid across European
dietary surveys (post-marketing scenario)
Level of exposure(a) Age class N
Total acute dietary exposure (% ARfD)
Minimum Median Maximum
LB UB LB UB LB UB
Mean Infants (3–6 months) 3 4.1 5.6 5.1 5.8 5.4 6.6
Infants (6–12 months) 6 3.5 5.9 4.0 6.9 4.4 8.0
Toddlers 11 3.3 7.0 3.8 7.6 5.3 10.3
95th percentile Infants (3–6 months) 3 9.0 10.7 9.4 12.0 13.0 13.7
Infants (6–12 months) 5 7.6 12.0 7.9 12.6 8.6 14.1
Toddlers 10 6.3 11.9 7.4 13.0 8.9 16.5
97.5th percentile Infants (3–6 months) 3 9.7 11.3 10.1 13.0 13.5 14.7
Infants (6–12 months) 5 8.6 13.9 9.1 14.8 10.7 16.2
Toddlers 7 7.2 12.9 8.7 14.5 10.0 16.9
LB: lower bound; N: number of surveys; UB: upper bound.
(a): The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations,
respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.
Table A.26: Average contribution of the background exposure to the total acute exposure of
thiacloprid across European dietary surveys (post-marketing scenario)
Distribution Age class N
Average contribution (% of total exposure)
Minimum Median Maximum
LB UB LB UB LB UB
Full(a) Infants (3–6 months) 3 0.3 12.9 0.6 21.1 1.2 24.1
Infants (6–12 months) 6 1.1 35.1 1.5 42.7 2.3 47.6
Toddlers 11 1.5 47.6 2.8 51.8 3.8 58.0
Upper tail(b) Infants (3–6 months) 3 0.1 19.2 0.2 19.8 0.4 38.2
Infants (6–12 months) 5 0.4 30.1 0.9 40.5 1.2 48.1
Toddlers 10 0.8 43.5 1.8 50.0 2.3 54.6
LB: lower bound; N: number of surveys; UB: upper bound.
(a): Average contribution refers to the full distribution of acute exposures calculated within a survey and age class.
(b): Average contribution refers to the acute exposures exceeding the 95th percentile within a survey and age class. Surveys
with less than 61 observations were excluded because the 95th percentile estimates obtained on these dietary surveys/age
classes were not considered statistically robust (EFSA, 2011a).
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Appendix B – Recent literature review on developing brain and brain
barriers
B.1. Brain and brain barriers
Since the closing of the literature review before the composition of the recent EFSA report a
number of reports have appeared that enrich our comprehension of the possible targets for pesticides
which may be developmental neurotoxicants. These and their possible implications for the vulnerability
of infants are considered in this section.
B.2. Neuronal plasticity
Recent work on brain development and brain barriers has underscored the temporal importance of
functional stimuli during brain development highlighting neuronal plasticity in the sensory systems and
linking this to autism, fragile -X and Rett syndromes (Chaudhury et al., 2015). Plasticity is also important
in brain development and speciﬁcally in the context of learning in the amygdala where brain-derived
neurotrophic factor, and other molecules work together to transduce extracellular signals (Ehrlich and
Josselyn, 2016). Autism has also been linked to disruption of usually continuous and signiﬁcant neural-
network structural development in infancy. This advance has occurred through observing changes that
have been detected by connectomics analysis (Cao et al., 2016). Further progress is also being made
using transcriptomics to understand the timing of some of the large number of key steps in cortical
development. These include healthy neuronal development in the prenatal and early postnatal period,
stem-cell division, progenitor cell proliferation, migration of neurons, architectural folding of the cortex
into lobes and gyri, synaptogenesis, neural circuit development, gliogenesis and myelination. A limitation
of these molecular methods is that they are point in time averages of events taking place at different
times in several different brain regions (Jiang and Nardelli, 2016).
B.3. Cellular and molecular neurodevelopmental biology
The level of cellular and molecular detail in descriptions of developmental processes such as
neuronal migration is increasing. Needed for correct positioning of cells in developing networks the key
events involved are being explained in terms of their functional components. For example axon
extension, nuclear approximation to centrosomes and the cytoskeletal and motor proteins involved in
the differentiation and correct positioning of neurons are now partly understood (Dantas et al., 2016).
These are of interest as some of the key molecules such as the motor proteins dynein and KIF1A when
inhibited experimentally cause different forms of microcephaly and lissencephaly conditions which are
sometimes observed in risk assessments where teratogenesis of pesticides has been a cause for
concern. It is likely that this level of understanding will be necessary to elaborate Adverse Outcome
Pathways (AOPs) for some of the health outcomes in the area of DNT.
Despite these advances, it is still the case that precise evidence is lacking for where and when in
human brain and brain barrier (BB) development the most potentially pesticide sensitive events are
occurring, although it is clear that there are many of these still to be described scientiﬁcally throughout
the early post-natal period and infancy.
B.4. Haemodynamics of the brain
Recent advances in non-invasive MRI techniques have allowed neonatal and infant brain
haemodynamics to be observed and quantitated in vivo (De Vis et al., 2016). Such studies are at an early
stage but offer the prospect of directly measuring effects on infant brain such as haemodynamic-induced
encephalopathy. Whilst apparently no case studies have yet been carried out on infants that are reported
to have been exposed to environmental factors such as pesticides (Richmond et al., 2016) there will
possibly be opportunities for advances in knowledge in future as these techniques develop.
B.5. Microbiome effects on brain development
The increasing interest in the gut microbiome has revealed that the establishment of microbiota at
birth can be disturbed with consequences for brain development and behaviour although without clear
understanding of linking mechanisms (Diaz Heijtz et al., 2011; O’Mahony et al., 2017). Some of these
are thought to be mediated through glial mechanisms (Tay et al., 2017).
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B.6. DHA
Amongst long-chain poly-unsaturated fatty acids (LCPUFA), a component speciﬁc to cell membranes in
the CNS is docosahexaenoic acid (DHA), an omega-3 fatty acid. It is synthesised at a low rate but
accumulates rapidly during the third trimester of pregnancy (via placental transport) and during the
2 years after birth from breast milk or formula. It is important for neurone growth, differentiation and
signalling in infancy. Its beneﬁcial effects on cognition are inconsistently observed at lower levels of
supplementation but seem to be consistent at supplementation levels above 1.4%. At this level, three
studies with high doses of DHA yielded some short-term beneﬁcial effects, two for cognition (i.e., 1.4%
fatty acid DHA) and one for vision (Isaacs et al., 2008). However, the long-term sustainability of these
effects remains to be demonstrated (Schneider and Garcia-Rodenas, 2017) and the level of DHA may
affect early development with some effects of supplementation suggested to affect behaviour. Its action is
genotype and gender speciﬁc. This physiological difference of the foetal and infant brain from that of the
adult and ageing brain is of interest should its accumulation be affected by a toxin (Lauritzen et al., 2016).
B.7. Neurovesicles in brain development
Recently, attention has been drawn to two populations of small vesicles (exosomes and
microvesicles) that shuttle proteins, lipids and RNA between donor and recipient cells in the developing
brain. The fact that these cells include neurones, glia, neuroepithelial and choroid plexus cells and that
amongst the contents of the vesicles are known morphogens shows that they are clearly relevant to
neurodevelopment (Morton and Feliciano, 2016). As yet nothing is known about the response of these
organelles to toxic effects of pesticides.
B.8. Links between the development of the CNS and the immune
system
i) Cancer metastasis
A study of cancer metastasis to the cerebrospinal ﬂuid (CSF) through the leptomeninges28 (which is
frequently fatal) has relevance (Ghannam et al., 2008). The ability of cancer cells to inﬁltrate and grow in
CSF has not been easy to understand as CSF is generally an acellular, mitogen-poor microenvironment
unsuitable for metastatic spread. The authors discovered that in the model disease process complement
component 3 (C3) was upregulated. This allowed cancer growth within the rat leptomeningeal space
where CSF is located. In human disease, cancer cells within the CSF also synthesise C3. Furthermore, it
was found that C3 concentration increased as the disease increased in severity. C3 expression in primary
tumours was also found to be predictive of leptomeningeal relapse. It appears from these studies that C3
activates the C3a receptor in the choroid plexus epithelium causing disruption of the blood-CSF barrier.
This effect allows plasma components such as mitogens to enter the CSF and stimulation of tumour
growth. Consistent with this interpretation, inhibition of C3 signalling suppressed leptomeningeal
metastasis in the rat preclinical models.
This article is particularly interesting as it indicates in human adults and rats a link between a
component of the complement cascade and the opening of one of the brain barriers (the blood
choroid plexus barrier). This suggests that the effect of neurotoxicants can be controlled by substances
that are part of the immune system providing a potential adverse outcome pathway for developmental
neurotoxicity following changes in the immune status of the very young. There is as yet no evidence
for the developmental age or stage at which this opening system becomes functional in humans.
However, C3 is present in humans and is consistently synthesised in the liver from 14 weeks of age,
and in some instances possibly earlier. This draws attention to a data gap, present for humans, that
could be ﬁlled by research. The fact that the process appears also to occur in rats is helpful as an
animal model for the study of the process is available.
ii) Anaphylatoxins (Ats)
The effects of the complement C3 pathway at this site as part of the innate immune system are of
interest as one small cleavage product of its proteolytic digestion is C3a that binds to receptors
throughout the brain, particularly on astrocytes and microglia (Saunders et al., 2000; Klos et al., 2009).
These anaphylotoxins, such as C3a and C5a, are bacteriocidal and cause inﬂammation.
28 The arachnoid and pia are together called the leptomeninges, literally ‘thin meninges’ whilst the dura mater is thicker.
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As potent mediators of inﬂammation, they control many responses that include vasodilation, small
blood vessel permeability and smooth muscle contraction. They trigger oxidative bursts of neutrophils,
macrophages, basophils and eosinophils, and cause histamine degranulation of mast cells, eosinophil
migration and attachment and serotonin release from platelets. They are a chemoattractant for
macrophages and modulate IL-6 and TNF-alpha synthesis by B cells and monocytes (Klos et al., 2009).
Beyond their inﬂammatory roles, they appear to regulate tissue regeneration, haematopoietic stem cell
homing and ﬁbrosis. Importantly, the C3a receptor has been suggested to have a role in the
development of the cerebellum (Bernard et al., 2004). Receptors for these anaphylatoxins C3aR and
C5aR are expressed in cerebellar granule neurons reaching their highest concentration in the 12-day-
old rat. It is difﬁcult to translate the timescale into human development terms but four rat days per
human year might allow a very rough estimate of equivalence of 3 years in humans (Eason et al.,
2004).
This additional evidence-linking components of the innate immune system with opening of the
blood–brain barrier and with developmental effects on the cerebellum can be viewed as potential parts
of developmental neurotoxicity adverse outcome pathways.
iii) Microglia
The roles of the glial system include the regulation of brain development and homeostasis via
microglial–neuronal interactions. These comprise but are not restricted to synaptic modelling, cellular
immune functions, removal of cellular debris, participation in BBs function and production of trophic
factors. The variety of roles, which includes effects on cognitive functions, may depend on
subpopulations of microglia which ﬁrst originate in the yolk sac (but later arise from haematopoietic
tissue) and come to colonise different brain niches by crossing leptomeninges. It is suggested that the
variety of forms are inﬂuenced by their local interactions with populations of neurones that have
different functions. One key location is the subventricular zone where chemoattractant processes cause
one group to coalesce. A recently described group of ‘dark microglia’ found in mouse hippocampus,
amygdala, hypothalamus and cortex shows evidence of oxidative stress and coalesce at synapses
where an observed role in a specialised form of synapse removal has been linked with
neurodegenerative conditions. This work is of interest but much further study will be required to
explore possible relevance to potential effects of pesticides in developing human infant brain (Tay et al.
2017). As with the differential gender effects of DHA supplementation, it is of interest to note the
possession of oestrogen and progesterone receptors on microglia. These properties are expected to
expose the brain to harm from endocrine active substances. Also, there are reports of disruption of
microglial function linked to the absence of a gut microbiome and alterations in gut microbiota (Tay
et al. 2017). It is worth pointing out that astroglia and microglia share a considerable repertoire of
functions and the roles of glia are considered ever more important in brain function and development
(Reemst et al., 2016). Functions shared by these two disparate forms of glia include roles in neuro-,
angio- and glio-genesis, axon growth, synaptogenesis and the pruning of synapses. Dysfunction may
result in neurodevelopmental conditions and possibly delayed onset neuropathology.
To summarise we are at a stage where a great deal of detail is now available concerning canonical
functions of the cellular, organellar and molecular components of the developing brain. There is,
however, a gulf to be crossed and a need for greater descriptive detail concerning the stages of
differentiation of brain regions with different functional roles and with adequate time resolution. With
this information, AOPs can be developed that will in future allow stage-speciﬁc experimental designs to
determine the sensitivity of the developing systems to be assessed in risk assessment.
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Appendix C – Therapeutic doses of pharmaceuticals in infants and young
children and comparison with doses in adults
List of medicines in clinical use with doses (p.o.) in infants above 16 weeks up to children of
3 years of age and corresponding doses (p.o.) in adults.
When doses are not provided in the references in mg/kg bw per day they were calculated by
assuming a weight of 10 kg for the paediatric dose and a weight of 70 kg for the adult dose. When a
range was given in the references, the mean value was used to calculate the ratio adult/infant.
Medicine (INN)
Dose (p.o.) infants > 4 months
up to children 3 years old
(mg/kg bw per day)
Dose (p.o.) adult
(mg/kg bw per
day)
Ratio adult/infant
(value > 1 indicates
that infant is more
sensitive)
Weight (used for
calculation)
10 kg 70 kg 7
Acetycystein 10–15 8.6 0.715
Acetylsalicylic acid 30–45 21.4–42.8 0.95
Albendazol 15 11.4 0.76
Amlodipine 0.05 0.07–0.14 1.2
Amoxicillin 24–48 21.4–28.6 0.7
Azithromycin 10 7.14 0.714
Captopril 2 6 3
Carbamazepine 35 22.8 0.65
Carvedilol 0.05 0.178 3.6
Cefaclor 40 42.85 1.1
Cefadroxil 100 57.1 0.57
Cefazolin 100 171 1.7
Cefepim 150 85 0.57
Ceﬁxim 8–12 5.7 0.7
Cefpodoxime 8–10 11.4 1.1
Cefuroxime 20–30 14.3 0.57
Cephalexin 40 42.85 1.1
Chloroquine 25–30 25–30 1
Cimetidine 15–30 28.5 0.95
Clarithromycin 15 14.3 0.95
Clindamycin 30 25.7 0.86
Clobazam 0.5–1 1.14 1.5
Clonidine 0.025 0.01285 0.5
Desloratadine 0.1 0.07 0.7
Diclofenac 1–3 1.4–2.8 1
Digoxin 0.01 0.0036 0.36
Dimenhydrinate 5 5.7 1.1
Dimetindenmaleat 0.15–0.225 0.08 0.53
Doxylamine succinate 0.625–1.25 0.35–0.7 0.57
Enalapril 0.5 0.6 1.1
Ethosuximide 15–40 14.3 0.5
Flucloxacillin 40–50 171.4 3.8
Fluconazol 6–12 5.7 0.63
Fluconazole 3–12 5.7 0.76
Fosfomycin 100–300 285 1.43
Furosemid 1–2 1.7 1.1
Hydrochlorothiazide 1–3 1.42 0.71
Ibuprofen 30–60 45.7 1.01
Isoniacid 8–10 8 0.9
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Medicine (INN)
Dose (p.o.) infants > 4 months
up to children 3 years old
(mg/kg bw per day)
Dose (p.o.) adult
(mg/kg bw per
day)
Ratio adult/infant
(value > 1 indicates
that infant is more
sensitive)
Ketotifen 0.1 0.11 1.1
Lacosamide 10 8.6 0.86
Levetiracetam 20–60 42.9 1.1
Linezolid 30 17.1 0.58
Loracarbef 15–30 11.4 0.5
Lorazepam 0.4 0.14 0.36
Meropenem 30–60 42 0.95
Metamizol 32–64 57.1 1.2
Metildogoxin 0.008 0.004 0.5
Metolazone 0.2–0.4 0.07–0.14 0.36
Metronidazol 20–30 28 1.14
Morphin 1.8 1.8 1
Naproxen 15 17.85 1.2
Neostigminmethylsulfat 0.6 0.14 0.23
Niclosamid 25 14.2 0.57
Nitrofurantoin 5 5 1
Omeprazol 3.5 1.7 0.5
Oxacillin 80–160 171 1.43
Paracetamol 40–60 40–60 1
Penicillin V 15–63 50.6 2.1
Pethidin 3–12 2.1–12.8 1
Phenobarbital 5–10 1–3 0.27
Pipamperon 2-4-6 1.7–5.1 1
Propafenon 10–20 12.8 0.96
Propiverin 0.7–0.9 0.21–0.63 0.52
Propranolol 8 4.6 0.57
Ranitidin 4–8 4.3–12.9 1.6
Rifampicin 15 17 1.1
Roxithromycin 5–7.5 4.3 0.7
Spironolactone 1–3 1.4–2.8 1.15
Sulfamethazol 60 34.3 0.57
Sultamicillin 50 21.4 0.43
Sultiam 5–10 5–10 1
Terbutalin 0.15–0.45 0.21 0.7
Theophyllin 18 13 0.7
Topiramate 5–9 7.14 1.0
Tramadol 12 8.6 0.7
Trimethoprim 12 6.8 0.57
Ursodesoxycholic acid 10–15 10–15 1
Valproic acid 30–60 14.3–35.7 0.56
Vancomycin 40 28.6 0.7
Verapamil 4 6.8 1.7
Vigabatrin 40 14.3 0.35
Mean value (n = 82) 0.95
SD 0.61
Range 0.23–3.8
Information extracted from:
(a): MacPeds Formulary, a document used in McMaster Children’s Hospital (MCH), McMaster and St Joseph’s Healthcare, Canada.
(b): Medicine Base, Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany. www.drugbase.de last accessed 09 January 2018.
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Appendix D – Hydrolysis studies for residue deﬁnition
Hydrolysis data of 111 approved active substances having a single compound residue deﬁnition
(SCRD), used for the assessment of the appropriateness of residue deﬁnition established under
Regulation (EC) No 396/2005 (chapter 7).
Substance
Minimum recovery
per a.s. (90°C,
20 min, pH 4)
Minimum recovery
per a.s. (100°C,
60 min, pH 5)
Minimum recovery
per a.s. (120°C,
20 min, pH 6)
1 Aclonifen 96.7 96.8 98.0
2 Amisulbrom 89.9 49.3 11.5
3 Azoxystrobin 100.9 96.2 100.1
4 Beﬂubutamid 104.4 95.4 98.5
5 Alpha-Cypermethrin
(aka alphamethrin)
99.7 97.6 54.7
6 Benalaxyl 101.0 102.0 98.0
7 Benthiavalicarb 94.8 96.5 93.9
8 Benzovindiﬂupyr 100.0 100.0 100.0
9 Beta-Cyﬂuthrin 106.5 99.7 12.1
10 Bifenthrin 49.0 31.0 81.3
11 Bupirimate 94.9 95.6 91.1
12 Buprofezin 28.2 30.5 76.0
13 Chlorantraniliprole 98.4 85.9 96.2
14 Chlormequat 101.0 99.1
15 Chlorpyrifos 74.6 19.8 0.8
16 Chromafenozide 94.4
17 Clopyralid 99.3 96.9 97.1
18 Clothianidin 100.0 100.0 100.0
19 Cyantraniliprole 98.6 98.8 100.2
20 Cyazofamid 18.6 0.0 0.0
21 Cyﬂumetofen 69.3 5.0 0.0
22 Cymoxanil 11.8
23 Cypermethrin 95.2 96.9 54.7
24 Cyproconazole 96.6 101.0 97.0
25 Cyromazine 99.9 99.1 100.6
26 Deltamethrin 94.8 94.0 25.6
27 Desmedipham 81.8 0.0 0.0
28 Dicamba 100.7 105.1 107.6
29 Diethofencarb 98.8 98.7 98.2
30 Difenoconazole 95.6 96.0 98.6
31 Dimethenamid-P 96.3 98.6 95.1
32 Dimethomorph 98.1 93.0 99.0
33 Dimoxystrobin 97.7 94.4 0.0
34 Dithianon 28.1 1.0 0.0
35 Dodine 97.1 91.8 94.7
36 Emamectin 84.4 85.9 79.8
37 Epoxiconazole 92.5 97.6 97.6
38 Ethephon 80.5 0.0 0.0
39 Etofenprox 95.6 93.0 94.3
40 Etoxazole 72.2 62.8 59.9
41 Famoxadone 96.2 66.0 43.3
42 Fenamidone 90.1 100.1 102.6
43 Fenazaquin 35.0 61.6 79.4
Scientiﬁc Opinion on pesticides in foods for infants and young children
www.efsa.europa.eu/efsajournal 70 EFSA Journal 2018;16(6):5286
Substance
Minimum recovery
per a.s. (90°C,
20 min, pH 4)
Minimum recovery
per a.s. (100°C,
60 min, pH 5)
Minimum recovery
per a.s. (120°C,
20 min, pH 6)
44 Fenbuconazole 100.7 97.7 104.6
45 Fenhexamid 99.7 95.7 100.2
46 Fenoxycarb 92.2 94.7 95.3
47 Fenpyrazamine 95.1 99.8 89.1
48 Flubendiamide 101.0 100.9 99.8
49 Fluopicolide 98.9 103.8 100.4
50 Fluoxastrobin 95.3 102.6 98.2
51 Flupyradifurone 100.0 100.0 100.0
52 Fluquinconazole 99.0 91.2
53 Fluxapyroxad 100.0 100.0 100.0
54 Formetanate 88.5 0.6 1.4
55 Fosthiazate 82.6 79.2
56 Hymexazol 100.0 100.0 100.0
57 Imazamox 102.2 103.5 95.2
58 Imidacloprid 97.7 99.2 98.1
59 Indoxacarb 88.0 69.0
60 Iprovalicarb 98.1 97.2 96.9
61 Isofetamid 99.2 97.8 96.8
62 Isopyrazam 96.1 98.6 98.4
63 Lambda-Cyhalothrin 87.8 82.6 7.8
64 Lufenuron 100.3 95.4 107.2
65 Mandestrobin 94.2 99.8 99.6
66 Mandipropamid 104.9 103.4 109.1
67 Mepanipyrim 101.1 105.7 97.9
68 Mepiquat 95.1 96.6 94.9
69 Metaﬂumizone 77.0 62.1 89.4
70 Metalaxyl-M 98.6 100.6 99.3
71 Methoxyfenozide 97.7 95.9 96.1
72 Methomyl 93.7 86.5 58.2
73 Metrafenone 100.5 101.4 94.8
74 Metribuzin 97.6 97.9 97.8
75 Oxamyl 100.0 57.8 0.0
76 Oxathiapiprolin 94.8 94.7 93.8
77 Penconazole 97.3 97.6 97.8
78 Pendimethalin 99.4 99.9 99.2
79 Penﬂufen 100.9 106.5 99.2
80 Penthiopyrad 101.5 102.1 99.8
81 Phenmedipham 87.3 0.0 0.0
82 Pinoxaden 86.2 72.3 53.5
83 Propiconazole 98.0 99.9 99.6
84 Propineb 62.1 26.4 1.6
85 Proquinazid 95.2 95.9 93.9
86 Prosulfocarb 91.5 94.1 94.6
87 Prothioconazole 99.4 99.9 100.3
88 Pyraclostrobin 98.1 0.0 2.5
89 Pyridaben 97.8 90.0 85.2
90 Pyridalyl 103.4 92.5 95.7
91 Pyriofenone 98.6 98.2 98.3
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Substance
Minimum recovery
per a.s. (90°C,
20 min, pH 4)
Minimum recovery
per a.s. (100°C,
60 min, pH 5)
Minimum recovery
per a.s. (120°C,
20 min, pH 6)
92 Quinmerac 97.2 103.3 96.2
93 Quizalofop-P 100.0
94 Sedaxane 98.9 99.4 99.3
95 Spinetoram 94.5 92.1 85.0
96 Spinosad 96.9 95.6 77.5
97 Spirodiclofen 99.1 35.4 37.3
98 Spiromesifen 70.8 13.4 0.9
99 Sulfoxaﬂor 99.6 100.0 100.4
100 Tau-Fluvalinate 90.9 40.8 1.7
101 Tebufenozide 100.0 100.0 100.0
102 Tebufenpyrad 100.0 102.4 115.4
103 Tetraconazole 98.7 97.5 97.5
104 Thiacloprid 98.1 96.5 97.0
105 Thiamethoxam 100.0 100.0 98.3
106 Thiencarbazone 36.4 2.6 0.0
107 Thiram 80.3 20.8 0.3
108 Tolclofos-methyl 61.7 33.6 12.6
109 Triadimenol 96.2 94.4 93.2
110 Triﬂumuron 98.4 88.9 51.4
111 Trinexapac (aka
cimetacarb ethyl)
52.5 58.5 50.9
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Appendix E – List of uncertainties
Detailed list of uncertainties summarised under Chapter 8:
ToR 1 – The assessment of the appropriateness of the toxicological reference values for pesticides
for infants and young children and of the approach to base the MRLs for pesticides for foods for
infants and young children on the acceptable daily intake (ADI) values (in this context, the assessment
of the short-term dietary risk should also be considered):
No. 1: Literature search was restricted to review articles published in WEB of Science for speciﬁc
timespans and carried out in English. Relevant references were identiﬁed by two independent WG
members based on inclusion criteria.
No. 2: Age and stage of development. Estimates of developmental stage equivalence between
animals and humans are not precise and a further source of uncertainty. There are also signiﬁcant
interindividual differences in humans in the stage of development at any time after parturition. This
evidence introduces uncertainty into the classiﬁcation of infants and toddlers for risk assessment based
on time after birth.
No. 3: In the newborn the brain, liver and kidney are relatively larger than in the adult and the
fraction of the body of an infant consisting of intracellular and extracellular water and of fat alters over
the ﬁrst year. Protein, fat and water compartments in the body change at different rates adding
uncertainty to predictions of local concentrations in the target organ, and hence, the extent of toxic
effects extrapolated from adults.
No. 4: Smaller surface areas in infant than adult as a result of a less elaborate convolution of the
gut lining may restrict absorption in the infant to an unknown, but limited degree for nutrients.
No. 5: Other intestinal maturational differences are expected to be the basis of physiological
differences. These include motility, transit time of food, gastric emptying and volume, pH of gut
contents and the expression of metabolizing enzymes and transporter molecules (Nicolas et al., 2017).
The variety of potential differences and the paucity of data add uncertainty to the risk assessment.
However, studies show that gastric emptying is slower and the rate of absorption reduced whereas the
extent of absorption is not. However, it is uncertain whether these observations of a small number of
substances are fully applicable to pesticides residues.
No. 6: Bile salts metabolism is active in the neonate, but the extent may change over the ﬁrst
8 months. There is therefore a contribution to uncertainty because of this reduced capacity in the
infant as compared with the adult (de Belle et al., 1979).
No. 7: Infants and children have a higher drinking water consumption per kilogram of bodyweight
than adults. This adds uncertainty to estimations of the uptake of water soluble residues.
No. 8: Closure is a stage in gut development that occurs after birth in some laboratory animals; but
in humans, this is functionally complete by 4 days after the start of oral feeding so will add uncertainty
in extrapolations from animal studies to humans.
No. 9: The human microbiome is important to health and physiology. Microbiota differ in their
species composition from one part of the body to another. In the GI tract, microorganisms produce
and modify substances with a variety of biological activities affecting host metabolism including
metabolism of bile acids and vitamins. Obesity, inﬂammatory bowel disorders and intestinal cancer
have been linked to alterations in the microbiome in early life. Particular bacterial species are required
during speciﬁc developmental stages to ensure a healthy pattern of host immunity. In infancy, it is
developed to a stage where it can inﬂuence health and development. This is in some cases a known
effect of diet, but there is a small amount of evidence that it could be affected by pesticide residues
(Derrick et al., 2017; Claus et al., 2016). Further research is needed to establish the role of currently
approved pesticides and to determine if they contribute to the risk assessment by effects mediated by
the developing microbiome.
No. 10: The main toxicokinetic differences concern reduced clearance from the body. This leads to
a higher internal exposure at the same external exposure. These differences can be quantiﬁed at a
general level and if necessary corrected by an additional default uncertainty factor. For individual
substances, the additional default factor might be too high or too low.
No. 11: The lack of EOGRTS with the DIT/DNT is considered an important uncertainty that leads to
a recommendation.
ToR 2 – The assessment of the contribution of other foods consumed by infants and young
children that are not covered by Regulation (EU) No 609/2013:
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No. 12: Assessment of dietary intake in infants and young children is especially challenging. It
requires special methodology to consider age-speciﬁc food consumption habits and is further
complicated by the rapid growth changes that occur during a relatively short period of time. Not all
food served to an infant or young child is necessarily consumed, a signiﬁcant amount may be wasted.
This is expected to lead to overestimations of exposure. In addition, food consumption surveys may
not always be actual enough to reﬂect recent changes in infant and young child-feeding practices that
result from the changes in dietary recommendations from relevant authorities (Fewtrell et al., 2017).
As systematically repeated food consumption surveys, e.g. every 5 years as recommended for
breastfeeding monitoring (WHO UNICEF 2017), are mostly not available in infants and young children
at country level, there remains uncertainty about the timeliness of the food consumption data in the
EFSA Database.
No. 13: The conversion of EFSA’s Comprehensive Database into food consumption data for Raw
Primary Commodities (RPC) assumes the same proportions and probabilities of composite food
ingredients for all EU Member States while these are expected to vary according to cultural and even
individual practices. Furthermore, this conversion model was still under ﬁnalisation at the time of
performing the calculations. Previous experience has shown that inaccuracies in the conversion model
will tend to generate extreme consumption values, hereby mainly overestimating high-percentile
exposures. Mean exposure estimates were shown to be less sensitive for such inaccuracies.
No. 14: Premarketing scenarios have the implicit assumption that all foods were treated according
to the most critical conditions of use for a given pesticides (i.e. conditions of use assumed for deriving
the MRLs in conventional foods). Post-marketing data have demonstrated, however, that pesticide
concentrations in food are generally lower than those anticipated from the premarketing data.
Premarketing scenarios may overestimate actual exposure by a factor of 2–100 depending on the
active substance and dietary survey.
No. 15: Post-marketing data used for the exposure assessment may be obtained using different
analytical methods resulting in different LOQs. This fact together with the large proportion of samples
with left-censored results introduces uncertainty to the overall dietary exposure estimates for the
post-marketing scenario. While the lower bound (LB) values tend to underestimate the dietary
exposure to pesticides, UB values tend to overestimate it.
No. 16: Except for the effect of peeling observed for some active substances, losses of residues
during household or industrial preparation were not considered in the current assessment.
Incorporation of such processing factors in the exposure assessments may signiﬁcantly reduce the
exposure estimates.
ToR 3 – The impact of a cumulative exposure to pesticides which share a common toxicological
effect:
No. 17: No speciﬁc uncertainties relevant to the section of this opinion were identiﬁed as additional
to those already discussed in the references to the EFSA methodologies.
ToR 4-The appropriateness of residue deﬁnitions established under Regulation (EU) No 396/2005
for foods for infants and young children:
No. 18: Sources of inaccuracy are founded by potential changes of the molecular structure by
processing operations (see Chapter 7), which may not be covered by the residue deﬁnitions under Reg.
(EU) 396/2005. The other inaccuracy is based on the often divergent residue deﬁnitions of monitoring
and risk assessment, of which the latter may include additional metabolites (see chapter 5.2).
No. 19: The use of the ADME study conducted in rodent species is a relevant source of
uncertainties in regard to the approach for the residue deﬁnition, particularly when dealing with
metabolites observed in different species and in particular in the pups.
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Annex A – Calculations for exposure assessment: tables (xls)
Annex A can be found in the online version of this output (‘Supporting information’ section):
https://doi.org/10.2903/j.efsa.2018.5286
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